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RESUMO 
Ácidos húmicos (AHs) são macromoléculas derivadas de substâncias húmicas (SH), 
provenientes da degradação da matéria orgânica. Eles podem conter diversos grupos funcionais 
em sua composição, como fenóis, ácidos carboxílicos e quinonas, sendo responsáveis por 
muitas de suas funcionalidades, por exemplo, pelo seu caráter antioxidante e fungicida. Devido 
ao caráter anfifílico e à desprotonação dos grupos, os AHs podem formar estruturas micelares 
em água, sendo úteis para aplicações farmacêuticas tanto independente quanto encapsulando 
fármacos hidrofóbicos e interagindo com tensoativos, oferecendo novas aplicações 
tecnológicas. Neste contexto, o objetivo deste trabalho foi a produção e a caracterização de 
nanopartículas de AHs contendo o tensoativo Pluronic F127 (PF127). O emprego do PF127 
visou introduzir modificações estruturais nas micelas originais de AHs, possibilitando explorar 
as propriedades resultantes para aplicações farmacêuticas. Estudos de permeação em 
membranas sintéticas (poros de 30 nm) foram realizados visando caracterizar a elasticidade das 
partículas e simular sua permeação pelos poros da pele. A capacidade das partículas AH-PF127 
de carrear fármacos hidrofóbicos foi estudada utilizando a curcumina. A atividade antioxidante 
dos AHs foi avaliada utilizando-se ensaios espectrofotométricos de sequestro dos radicais 
ABTS e DPPH. Além disso, foram realizados ensaios de atividade fungicida usando Candida 
albicans para AHs e AH-PF127. Os AHs comerciais foram caracterizados por análise elementar 
CNHS e quanto à composição de grupos fenólicos e carboxílicos pelas técnicas de RMN 13C, 
EM-CG e FTIR, onde aproximadamente 30% do total de sua composição correspondeu a estes 
grupos. Quinonas não foram identificadas pelas técnicas, não sendo, portanto, observada 
atividade fungicida na amostra. As interações entre AHs e PF127 foram favorecidas por maiores 
razões molares AH:PF127 (1:8), resultando em nanopartículas esféricas, estáveis, de diâmetro 
médio e potencial zeta de aproximadamente 100 nm e -30 mV, respectivamente. O PF127 
mostrou-se capaz de facilitar a permeação dos AHs pelas membranas sem apresentar agregação 
das partículas sob pressão transepidérmica (2,5 x 105 Pa), além de aumentar a eficiência de 
encapsulação da curcumina em relação às micelas de PF127. Finalmente, foi observado que em 
pH neutro, os AHs possuem atividade antioxidante dependente da concentração apenas quando 
a reação depende da transferência de elétrons e não de prótons. Este trabalho apresenta 
importante inovação tecnológica, contribuindo para a aplicação dos AHs na área farmacêutica. 
Palavras chave: ácidos húmicos; nanotecnologia; permeação em membranas; atividade 
antioxidante; atividade fungicida. 
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ABSTRACT 
Humic acids (HAs) are macromolecules derived from humic substances (HS), which come from 
the degradation of organic matter. HAs have many functional groups in their composition, such 
as phenols, carboxylic acids and quinones, which are responsible for many functionalities of 
the substance, such as their antioxidant and fungicidal activity. Due to the amphiphilic character 
and the presence of groups susceptible to exposure negative charges, HAs are able to form 
micelle-like structures in water, being useful for pharmaceutical applications both independent 
as by entrapping hydrophobic drugs and interacting with surfactants, which offers new 
technological applications. In this context, this work aimed the production and characterization 
of HAs nanoparticles containing Pluronic F127 (PF127). The use of PF127 aimed to introduce 
structural modifications in the original HAs micelles, in order to explore the resulting properties 
for pharmaceutical applications. Studies of synthetic membrane permeation (30 nm of pores) 
were conducted to characterize nanoparticles elasticity and simulate their permeation through 
skin pores. The ability of HA-PF127 particles to carry hydrophobic drugs was studied by using 
curcumin. In addition, spectrophotometric assays of the ABTS and DPPH free radicals 
scavenging were performed in order to evaluate the antioxidant activity of the nanoparticles. In 
addition, fungicidal activity assays were performed using Candida albicans for HAs and HA-
PF127. Commercial HAs were characterized by elemental analysis CNHS and for composition 
of phenolic and carboxylic groups by 13C NMR, GC-MS and FTIR, and approximately 30% of 
the total amount corresponded to these groups. Quinones were not identified by the techniques, 
and therefore, it was not observed fungicidal activity in the sample. The interactions between 
HAs and PF127 was favored by higher molar ratio HA:PF127 (1:8), resulting in spherical and 
physically stable nanoparticles, with mean diameter and potential zeta of approximately 100 
nm and -30 mV, respectively. PF127 showed to be able to facilitate the permeation of HAs 
through the membranes with no particles aggregation under the transepidermal pressure (2.5 x 
105 Pa), besides to increase encapsulation efficiency of curcumin compared to PF127 micelles. 
Finally, it was observed that in neutral pH, HAs had antioxidant activity in a concentration 
dependence manner when the reaction involved electron transfer, and not proton transfer. This 
work presented an important technological innovation, which contributes to the application of 
HAs in the pharmaceutical area. 
Key words: humic acids; nanotechnology; membrane permeation; antioxidant activity; 
fungicidal activity. 
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APRESENTAÇÃO 
Este trabalho foi redigido na forma de capítulos para melhor organização e discussão 
dos resultados obtidos, sendo este exemplar apresentado no seguinte formato: 
 Introdução;  
 Objetivo e metas;  
 Revisão de literatura, apresentada na forma de artigo científico; 
 Resultados e discussão, apresentados na forma de artigos científicos; 
 Conclusões; 
 Sugestões para trabalhos futuros; 
 Referências bibliográficas.
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1. INTRODUÇÃO 
Ácidos húmicos (AHs) são macromoléculas que compõem as substâncias húmicas (SH), 
matéria orgânica proveniente da decomposição de material animal e vegetal, estando presente 
no solo, água e sedimentos (Maccarthy 2001). Os AHs comerciais podem ser extraídos de 
carvão e turfa, duas fontes de carbono não renováveis, e, recentemente, tem sido evidenciada a 
sua produção por via biotecnológica a partir de resíduos do processamento de óleo de palma 
(Motta & Santana 2013). Além disso, os AHs também podem ser produzidos através de síntese 
química por reações de polimerização e condensação (Sławińska et al. 2007; Kiprop et al. 
2013).  
AHs são moléculas de alta complexidade estrutural, tendo porções hidrofóbicas e 
hidrofílicas, e diversos grupos funcionais em sua composição, tais como fenóis, ácidos 
carboxílicos, quinonas, dentre outros, os quais podem  variar de acordo com a origem e 
condições de obtenção (Stevenson 1994). Eles se diferem das outras frações das SH (ácidos 
fúlvicos e huminas) pela solubilidade, sendo completamente solúveis em meio alcalino, 
parcialmente solúveis em água e insolúveis em meio ácido (Stevenson 1994; Klučáková & 
Pekař 2005). Em pH básico, onde provavelmente os grupos fenólicos e carboxílicos estão 
desprotonados, as moléculas de AHs assumem uma configuração estendida, devido à repulsão 
eletrostática. Com a diminuição do pH ou aumento da força iônica, esses grupos são 
reprotonados resultando em agregação intra e intermolecular. Nesse caso, as moléculas 
enovelam-se formando estruturas do tipo micelas, também chamadas de “pseudomicelas”, onde 
as porções hidrofóbicas ficam voltadas para o interior da estrutura e as hidrofílicas em contato 
com o meio (von Wandruszka 2000). 
Estas características conferem aos AHs funcionalidades em diversas áreas, como na 
agricultura, onde eles são utilizados para melhorar o crescimento e nutrição de plantas, pois 
quando estão desprotonados podem transportar micro e macro nutrientes do solo para as raízes 
(Piccolo et al. 1992; Calvo et al. 2014). Eles também são utilizados na remediação da poluição, 
pois podem se ligar a metais pesados, tais como Hg2+, Pb2+, Cu2+, Cd2+ ou Mg2+, através de 
reações de quelação, removendo-os do solo e água (Stathi & Deligiannakis 2010; Sun et al. 
2015). Sua aplicação na medicina tem sido cada vez mais reconhecida e explorada, por 
exemplo, sua potencialidade de atuação como antivirais por serem capazes de se ligar a 
domínios catiônicos de vírus impedindo sua replicação, e como anti-inflamatórios, por 
impedirem a produção de citocinas inflamatórias (Neyts et al. 1992; van Rensburg 2015). 
Devido à presença de diversos grupos fenólicos e carboxílicos em sua estrutura, os AHs são 
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capazes de sequestrar radicais livres e, portanto, atuar como agente antioxidante. No entanto, 
ainda são escassos trabalhos na literatura que exploram esse potencial (Aeschbacher et al. 2012; 
Klüpfel et al. 2014).  
Além dos grupos fenólicos e carboxílicos, quinonas também podem compor os AHs. 
Essas moléculas se reduzem facilmente em semiquinonas, que por sua vez produzem espécies 
reativas de oxigênio (O2
-, OH, H2O2) em contato com o oxigênio molecular. A produção dessas 
espécies está relacionada com a capacidade dos AHs de cicatrizar feridas, agir no combate ao 
câncer e com sua atividade fungicida/bactericida (Jurcsik 1994; Klöcking & Helbig 2005; van 
Rensburg 2015; Hassett et al. 1987; Fujimura et al. 1994; Siddiqui et al. 2009).  
Muitas funcionalidades dos AHs estão relacionadas com o caráter anfifílico da 
molécula, o que tem sido muito útil na solubilização e remoção de poluentes hidrofóbicos do 
solo e água, especialmente hidrocarbonetos aromáticos policíclicos (HAPs) (Lassen & Carlsen 
1997; Tejeda-Agredano et al. 2014). Além disso, esse caráter pode favorecer a solubilização de 
fármacos hidrofóbicos, melhorando sua biodisponibilidade (Mirza et al. 2011; Martini et al. 
2010). Os AHs podem ainda interagir com tensoativos, também anfifílicos, através de 
interações hidrofóbicas, melhorando as propriedades dessas substâncias, como solubilidade e 
estabilidade (Otto et  al. 2003; Koopal et al. 2004).  
Tensoativos são muito usados na área farmacêutica, especialmente como emulsificantes 
e solubilizantes, sendo que os mais empregados são os não iônicos, por serem menos irritantes 
e de menor toxicidade (Nielloud & Marti-Mestres 2000). Dentre os tensoativos não iônicos 
estão os Poloxamers, também conhecidos como Pluronics, que são polímeros de bloco contendo 
poli(óxido de propileno) (PPO), sua porção hidrofílica, e poli(óxido de etileno) (PEO), sua 
porção hidrofóbica. Sua toxicidade varia de muito baixa para não tóxico com o aumento da 
massa molar ou da proporção de óxido de etileno na composição. Pluronic F127 (PF127) é 
reconhecido como sendo o menos tóxico deste grupo (Schmolka 1972) e, devido à sua não 
toxicidade e alta biocompatibilidade, este vem sendo utilizado há vários anos em aplicações 
farmacêuticas como solubilizante e carreador de fármacos (Gilbert et al. 1986; Grela et al. 2014; 
Mawad et al. 2008; Pradines et al. 2015).  
Neste contexto, o objetivo deste trabalho foi a produção e caracterização de 
nanopartículas de AHs por meio de sua adição gradual ao PF127, permitindo assim explorar as 
propriedades decorrentes dessas interações, visando o estudo de permeação em membranas 
sintéticas, capacidade de encapsular o bioativo curcumina e atividades antioxidante e fungicida 
das nanopartículas AH-PF127. O potencial das interações entre AHs e PF127 foi avaliado para 
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aplicações farmacêuticas (de Melo et al. 2015), uma vez que são inexistentes na literatura 
trabalhos envolvendo AHs e tensoativos com esse enfoque. Outra importante motivação foi a 
existência de poucos estudos com AHs visando aplicações na área farmacêutica.  
A dissertação deste trabalho de pesquisa será apresentada na forma de artigos 
científicos. A revisão de literatura será apresentada por meio do artigo de revisão “Humic acids: 
structural properties and multiple functionalities for novel technological developments” e os 
resultados e discussão do trabalho pelos artigos “The interactions between humic acids and 
Pluronic F127 produce nanoparticles useful for pharmaceutical applications” e “The effects 
of Pluronic F127 on membrane permeation, curcumin entrapment and antioxidant activity of 
humic acids nanoparticles”. 
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2. OBJETIVO E METAS 
O objetivo principal deste trabalho foi a produção e caracterização de nanopartículas 
de AHs incorporando o tensoativo PF127 e a exploração das suas propriedades para aplicações 
farmacêuticas.  
Este trabalho foi composto das seguintes metas: 
 Caracterização de AHs comerciais pelas técnicas de análise elementar CNHS, 
ressonância magnética nuclear no carbono 13 (RMN 13C), espectrometria de massas-
cromatografia gasosa com pirólise acoplada (EM-CG) e espectroscopia no infravermelho por 
transformada de Fourier (FTIR); 
 Produção de nanopartículas AH-PF127 por meio de adição de AHs à solução de 
tensoativo PF127 sob agitação controlada, visando a otimização da razão AH/PF127; 
 Estudo de permeação das partículas de AH-PF127 produzidas em membranas de 
policarbonato de poros de 30 nm, visando simular sua capacidade de permeação pelos poros da 
pele e sua utilização para aplicação tópica; 
 Estudo da capacidade de encapsulação de fármacos hidrofóbicos das nanopartículas 
AH-PF127, utilizando-se curcumina como substância ativa; 
 Investigação da atividade antioxidante das nanopartículas AH-PF127 pelos 
métodos de sequestro dos radicais (2,2-azinobis-[3-etil-benzotiazolin-6-ácido sulfônico]) 
(ABTS) e 2,2-difenil-1-picril-hidrazil (DPPH); 
 Investigação da atividade fungicida dos AHs e AH-PF127 utilizando-se o fungo 
Candida albicans.  
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3. REVISÃO BIBLIOGRÁFICA 
Esta seção será apresentada na forma de artigo de revisão, Humic acids: structural 
properties and multiple functionalities for novel technological developments, o qual descreve 
as principais funcionalidades dos AHs associadas à sua estrutura e propriedades. Esta revisão 
científica visou ressaltar novas perspectivas de desenvolvimento tecnológico envolvendo os 
AHs, principalmente para sua aplicação farmacêutica. 
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3.1. Humic acids: structural properties and multiple functionalities for novel 
technological developments 
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Humic acids: structural properties and multiple functionalities for novel technological 
developments 
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ABSTRACT 
Humic acids (HAs) are macromolecules that comprise humic substances (HS), which are 
organic matter distributed in terrestrial soil, natural water, and sediment. HAs differ from the 
other HS fractions (fulvic acid and humins) in that they are soluble in alkaline media, partially 
soluble in water, and insoluble in acidic media. Due to their amphiphilic character, HAs form 
micelle-like structures in neutral to acidic conditions, which are useful in agriculture, pollution 
remediation, medicine and pharmaceuticals. HAs have undefined compositions that vary 
according to the origin, process of obtainment, and functional groups present in their structures, 
such as quinones, phenols, and carboxylic acids. Quinones are responsible for the formation of 
reactive oxygen species (ROS) in HAs, which are useful for wound healing and have 
fungicidal/bactericidal properties. Phenols and carboxylic acids deprotonate in neutral and 
alkaline media and are responsible for various other functions, such as the antioxidant and anti-
inflammatory properties of HAs. In particular, the presence of phenolic groups in HAs provides 
antioxidant properties due to their free radical scavenging capacity. This paper describes the 
main multifunctionalities of HAs associated with their structures and properties, focusing on 
human health applications, and we note perspectives that may lead to novel technological 
developments. To the best of our knowledge, this is the first review to address this topic from 
this approach. 
Keywords: Humic acids. Humic substances. Reactive oxygen species. Antioxidant. 
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1. Introduction  
Humic acids (HAs) are macromolecules that comprise humic substances (HS), which 
are organic matter distributed in terrestrial soil, natural water, and sediments resulting from the 
decay of vegetable and natural residues (Maccarthy 2001). Commercial HAs are extracted from 
peat and coal, which are non-renewable sources of carbon. Recently, it was demonstrated that 
HAs could be produced by fermentation using the empty fruit bunch (EFB) of palm trees as a 
substrate, which is a natural and sustainable resource (Motta & Santana 2013). Furthermore, 
chemical synthesis can also be used to produce HAs through polymerization/condensation 
reactions (Kiprop et al. 2013; Sławińska et al. 2007). 
HAs are the fractions of HS that are soluble in alkaline media, partially soluble in water 
and insoluble in acidic media (Klučáková & Pekař 2005; Stevenson 1994). This classification 
parameter may vary with the HAs composition, pH, and ionic strength (Kipton et al. 1992). Due 
to their amphiphilic character, HAs form micelle-like structures, called pseudomicelles in 
neutral to acidic conditions (von Wandruszka et al. 1997; von Wandruszka 2000). This property 
has been explored for use in pollution remediation (Johnson & John 1999; Lassen & Carlsen 
1997; Lassen & Carlsen 1999; Tejeda-Agredano et al. 2014; Van Stempvoort & Lesage 2002) 
and to increase the water solubility of hydrophobic drugs (Martini et al. 2010; Mirza et al. 
2011). 
HAs contain different functional groups whose quantities depend on the origin, age, 
climate, and environmental conditions of extraction/production of the HAs (Sposito 1986; 
Steelink 1985; Stevenson 1994). The various functions of HAs are mainly attributable to the 
phenol and carboxylic acid functional groups (Perdue 1985), which allow the deprotonation of 
OH/OOH. This situation provides HAs with many capabilities, such as the improvement of 
plant growth and nutrition (Chen & Stevenson 1986; Chen 1996; Piccolo et al. 1992; Tahir et 
al. 2011), complexation with heavy metals (Yates & von Wandruszka 1999), and antiviral and 
anti-inflammatory activity (Junek et al. 2009; Klöcking & Helbig 2005; Neyts et al. 1992; 
Schols et al. 1991; Zanetti 1995). In addition, the presence of phenols, carboxylic acids and 
quinones in the structure of HAs is related to their antioxidant, antimutagenic/desmutagenic 
and fungicidal/bactericidal activities (Ferrara et al. 2006; Hassett et al. 1987; Khil’ko et al. 
2011; Siddiqui et al. 2009).  
The use of HAs is quite consolidated in agriculture (Nardi & Pizzeghello 2002; Vaughan 
& Malcom 1985) and pollution remediation (Perminova et al. 2002; Rashid 1985). Recently, 
review articles by Calvo et al. (2014) and Canellas et al. (2015) addressed the specific effects 
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of HAs on plants and their role on the plant growth, yield and nutrient uptake. Meanwhile, Tang 
et al. (2014) and Sun et al. (2015) discussed the importance of HAs in the treatment of water 
and waste gas, respectively. In medicine, HAs have been studied for the treatment and 
prevention of diseases (Ferrara et al. 2006; Jurcsik 1994; Legname et al. 2011; Sato et al. 1986). 
The main medical aspects and applications of HAs were described by Klöcking & Helbig 
(2005). More recently, van Rensburg (2015) highlighted the anti-inflammatory properties of 
HS in a mini-review. However, the application of HAs in the pharmaceutical and cosmetic 
fields has not been well explored despite their great potential, such as in the solubilization of 
hydrophobic drugs, in UV-visible absorption and as an antioxidant (Khil’ko et al. 2011; 
Klöcking et al. 2013; Martini et al. 2010; Mirza et al. 2011). In previous work, we demonstrated 
that HAs interact with Pluronic F127 (PF127) to form stable nanoparticles, which can be used 
for pharmaceutical applications as-is or after entrapping nonpolar drugs (de Melo et al. 2015). 
In 2005, Peña-Méndez et al. (2005) noted the applications of HS in environmental and 
biomedical applications. However, there is a lack of published studies that bring together all 
the functional effects of HAs related to their structural properties, as well as their toxicity and 
applications, especially in pharmaceutical and cosmetic areas.  
Therefore, this review aims to be the first to present the multifunctionalities of HAs, 
associating them with their structure and properties, and note novel technological 
developments. Moreover, the role of HAs in human health is highlighted.  
 
2. HAs structure and composition  
The chemical composition of HAs can vary according to geographical origin, age, 
climate and biological conditions, making the precise characterization of these substances 
difficult (Thorn et al. 1989). Their molecular weights are in the range of 2.0 to 1,300 kDa 
(Steelink 1985), and they contain many functional groups, as shown in Figure 3.1.1. HAs are 
mainly composed of phenolic, carboxylic acid, enolic, quinone, and ether functional groups but 
may also include sugars and peptides (Stevenson 1994). However, the phenolic and carboxylic 
groups are more prevalent in HAs structures. The huge structure of an HA molecule is 
composed of hydrophilic portions, consisting of OH groups, and hydrophobic portions, 
consisting of aliphatic chains and aromatic rings. 
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Figure 3.1.1. Model of HA structure. Figure adapted with permission from Mirza et al. (2011). Copyright (2011) 
Taylor & Francis Ltd (www.tandfonline.com). 
The phenolic and carboxylic groups are responsible for the weak acid behavior of HAs. 
The total acidity (phenolic + carboxylic group acidity) of the compounds extracted from soil, 
water, and geologic deposits was found to be approximately 6 meq g-1 (Schnitzer 1977).  
Quinones are electron-accepting groups and are responsible for the production of 
reactive oxygen species (ROS). They are reduced to semiquinones, which are stabilized by their 
aromatic rings and further reduced into hydroquinones, which are even more stable (Figure 
3.1.2) (Scott et al. 1998). 
  
 
Figure 3.1.2. Quinone, semiquinone, and hydroquinone structures and their oxy-redox reactions. 
Aeschbacher et al. (2012) evaluated the electron-accepting (quinone) and electron-
donating (phenol) moieties in HAs obtained from different sources. The origin and age of these 
substances was found to have a direct effect on their redox properties. 13C NMR analyses have 
shown that aquatic HAs have higher numbers of electron-donating and lower numbers of 
electron-accepting moieties than terrestrial HAs, as verified by Scott et al. (1998). The authors 
-
.
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supported the hypothesis that the phenolic groups in HAs slow the oxidative transformation of 
quinones, increasing their permanence in oxic environments.  
There is an agreement in the literature on the average elemental composition of HAs 
extracted from different sources, including commercial HAs, which are approximately 50% C, 
35% O, and 5% H, with the remaining percentage distributed between N and S, as shown in 
Table 3.1.1. 
Table 3.1.1. Elemental compositions of HAs extracted from different sources. 
HAs C (%) H (%) N (%) O (%) S (%) References 
Commercial 
(Sigma-Aldrich) 
55.6 5.5 4.5 34.4 1.2 
(Siddiqui et al. 
2009) 
Soil IHSS 
standard 
58.1 3.7 4.1 34.1 --- 
(Velasco et al. 
2004) 
Peat soil 50.4 4.9 2.8 39.1 0.7 (Sato et al. 1986) 
Sediments 43.7 - 53.8 4.1 - 5.8 3.5 - 6.2 31.1 - 37.1 --- 
(van Rensburg 
2015) 
Sewage sludge 52.8 6.8 6.5 33.9 0.1 
(Klavins & 
Purmalis 2010) 
EFB* 56.3 5.7 4.4 32.9 1.2 
(Hassett et al. 
1987) 
River 51.2 4.7 2.6 40.4 1.9 
(Rice & MacCarthy 
1991) 
Leonardite 63.8 3.7 1.2 31.3 --- 
(Velasco et al. 
2004) 
* EFB- Empty Fruit Bunch  
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3. HAs properties 
The main properties of HAs, such as solubility, pH dependence, interaction with 
hydrophobic groups, and metal chelation, are related to their structure, i.e., their amphiphilicity 
and the different functional groups that comprise each molecule. Table 3.1.2 shows the 
functional effects of HAs used in different applications 
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Table 3.1.2. Applications of HAs and their functional effects related to their structures. 
HAs technological 
application 
Functional effects Structural properties References 
Pollution 
remediation 
 
Chelates heavy metals 
 
 
 
Solubilizes hydrophobic 
pollutants 
 
OH/OOH deprotonation 
 
 
 
Amphiphilic character 
(De la Rosa et al. 2011; Kalina et al. 2013; Perminova 
et al. 2002; Rashid 1985; Stathi & Deligiannakis 2010; 
Sun et al. 2015; Tang et al. 2014; Wang et al. 2011; 
Yates & von Wandruszka 1999) 
 
(Gadad et al. 2007; Johnson & John 1999; Lassen & 
Carlsen 1997; Lassen & Carlsen 1999; Lu et al. 2009; 
Tejeda-Agredano et al. 2014; Van Stempvoort & 
Lesage 2002) 
Agriculture 
 
Plant growth and nutrition 
 
 
Plant growth and nutrition 
 
Bactericidal 
 
Fungicidal 
 
OH/OOH deprotonation 
 
 
Production of active oxygen (ROS) 
 
Production of active oxygen (ROS) 
 
Production of active oxygen (ROS) 
(Canellas et al. 2015; Nardi & Pizzeghello 2002; 
Piccolo et al. 1992; Tahir et al. 2011; Vaughan & 
Malcom 1985)  
 
(Calvo et al. 2014; Cordeiro et al. 2011; García et al. 
2014; Suzuki et al. 2012) 
 
(Fujimura et al. 1994; Hassett et al. 1987) 
 
 (Siddiqui et al. 2009) 
 
 
Medicine 
 
 
 
 
Antiviral 
 
 
Anti-inflammatory 
 
 
OH/OOH deprotonation 
 
 
OH/OOH deprotonation 
 
(Klöcking & Helbig 2005; Klöcking et al. 2013; Neyts 
et al. 1992; Schols et al. 1991; Schultz et al. 1972; 
Zanetti 1995) 
 
(Galzigna et al. 1998; Gandy et al. 2010; Jooné & van 
Rensburg 2004; Junek et al. 2009; Klöcking & Helbig 
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Medicine 
 
 
 
Antimutagenic/Desmutagenic 
 
 
Wound healing 
  
 
 Cancer therapy 
 
 
Prion disease therapy 
 
 
 
Presence of OOH  
 
 
Production of active oxygen (ROS) 
 
 
Production of active oxygen (ROS) 
 
 
OH/OOH deprotonation 
2005; van Rensburg 2015; van Rensburg & Naude 
2009) 
 
(Cozzi et al. 2015; Ferrara et al. 2004; Ferrara et al. 
2006; Marova et al. 2011; Sato et al. 1986)  
 
(Brzozowski et al. 1994; Jurcsik 1994; Klöcking & 
Helbig 2005; Kononova 1966; van Rensburg 2015)  
 
(Endo et al. 2014; Jurcsik 1994; Morales et al. 2013; 
Pan et al. 2000; Sagar & Green 2009) 
 
 
(Calvo et al. 2014) 
Pharmaceutical 
and cosmetic 
UV-vis protection 
 
 
 
Antioxidant 
 
 
Drug solubilizer and carrier 
UV-vis absorption 
 
 
 
Presence of OH 
 
 
Amphiphilic character 
(Klöcking et al. 2013; Pant et al. 2012; Sławińska et al. 
2007) 
 
(Aeschbacher et al. 2012; Avvakumova et al. 2011; 
Dhanapal & Sekar 2014; Khil’ko et al. 2011; Kučerík 
et al. 2008; Tarasova et al. 2015; Vašková et al. 2011) 
 
(de Melo et al. 2015; Ghosal 2003; Khanna et al. 2010; 
Martini et al. 2010; Mirza et al. 2011; Mirza et al. 
2012) 
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3.1. Solubility and pH dependence 
HAs are generally considered soluble in neutral to alkaline conditions (Stevenson 1994). 
This property varies with the chemical composition of these substances and thereby with their 
origin.  
In alkaline media, phenolic and carboxylic groups are deprotonated, and the repulsion 
of these negatively charged groups causes the molecules to assume a stretched configuration. 
Upon decreasing the pH, the functional groups are protonated, and the effects of repulsion are 
minimized, causing the molecule to adopt a coiled and compact structure. In this stage, the 
hydrophobic portions are in the interior of the structure, and the hydrophilic portions are in 
contact with the aqueous medium. This behavior is responsible for the detergent characteristics 
of HAs, their micelle-like organization, and the decrease of the superficial tension. These 
molecules form aggregates on an intramolecular level, followed by intermolecular aggregation 
and ultimately precipitation, as suggested by von Wandruszka (2000) and shown in Figure 
3.1.3. 
 
Figure 3.1.3. Behavior of HAs molecules in alkaline conditions and the aggregation process upon pH reduction. 
Alkaline pH: charge repulsion (A). Decreasing pH: intramolecular aggregation (B). Decreasing pH: 
intermolecular aggregation (C). Acidic pH: precipitation (D). 
Prado et al. (2011) have noted that pH is related to not only the solubility but also the 
stability of aqueous suspensions of HAs. A diffuse electric double layer is formed around the 
charged particles, protecting them and allowing the system to become uncharged. Moreover, 
the ion concentrations determine the particles’ charge protection, which is greater for lower 
ionic strength systems because the ionic species will have a stronger interaction with the electric 
layer than with the solvent molecules. 
At neutral pH, the solubilization of HAs is only partial. Although HAs can be found 
dissolved in water in nature, not all isolated solid preparations will dissolve. Klučáková & Pekař 
(2005) proposed different dissolution mechanisms for a lignite HAs-water suspension in which 
the solid has insoluble and soluble fractions. Because HAs are a weak polyelectrolyte, they can 
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exist in water as dissolved molecules and in the dissociated form (Eq. 1). This mechanism 
corresponds to the soluble fraction of HAs. The insoluble fraction interacts with the 
environment through the surface and acts as an ion-exchanger by releasing H+ ions into solution 
while anions remain insoluble (Eq. 2).  
HA(s)          HA(aq)             H
+
(aq) + A
-
(aq) Eq. 1 
HA(s)             H
+
(aq) + A
-
(s) Eq. 2 
Therefore, the dissolution of HAs molecules in water is more complex than that of 
common sparingly soluble solids because HAs are not a single component but a mixture of 
components, only some of which are soluble in water.  
 
3.2. Amphiphilic character 
Many studies in the literature have reported the use of HAs as an alternative for 
solubilizing nonpolar substances in aqueous environments (Johnson & John 1999; Lassen & 
Carlsen 1997; Lassen & Carlsen 1999; Tejeda-Agredano et al. 2014; Van Stempvoort & Lesage 
2002), with greater emphasis on their interaction with polycyclic aromatic hydrocarbons 
(PAHs), which are relatively insoluble in water and exhibit toxicity and carcinogenicity. The 
interactions between HAs and these nonpolar contaminants are noncovalent, and these 
compounds are solubilized at the hydrophobic core of HAs pseudomicelles (Yates & von 
Wandruszka 1999).  
 
3.2.1. Solubilization of hydrophobics 
Lassen & Carlsen (1999) verified the effect of dissolved commercial HAs in solubilizing 
solid fluorene and its heteroanalogs: carbazole, dibenzofuran, and dibenzothiophene. The PAHs 
were dispersed in water containing different amounts of HAs, and an increase in the apparent 
aqueous solubility of all PAHs that was also affected by HAs concentration was observed. The 
solubility of fluorene increased by 50% in the presence of 0-200 mg L-1 HAs, while the 
solubility of dibenzothiophene increased by more than 600% in the presence of 0-100 mg L-1 
HAs. Furthermore, it was found that HAs adsorb to dispersed PAHs particles, but this sorption 
competes with the dissolution mechanism. Thus, lower sorption leads to a stronger solubility 
effect of HAs on the PAHs particles. The constant of interaction, K, will vary among PAHs and 
decreases as the concentration of HAs in the solution increases. This behavior may be related 
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to changes in the conformation of the HAs structure, which tends to coil up with increasing 
HAs concentration, as also found with decreasing pH and increasing ionic strength (Ghosh & 
M. Schnitzer 1980). This coiling restricts the hydrophobic interaction between the two 
substances because the nonpolar fraction of HAs is located in the inner portion of the structure. 
More recently, Tejeda-Agredano et al. (2014) investigated the influence of HAs on the 
biodegradation of PAHs by microorganisms. The availability of these compounds to 
microorganisms is affected by their low water solubility, which interferes with their dissipation 
in polluted soil and sediments. Their study showed that the degradation of pyrene at a 
concentration above its solubility was significantly faster in the presence of HAs. On the other 
hand, HAs can inhibit cell adhesion on PAHs surfaces, limiting the biodegradation process. 
In the medical, pharmaceutical, and cosmetic areas, different strategies for increasing 
the aqueous solubility of nonpolar compounds have been explored recently using such carriers 
as lipid nanoparticles (Severino et al. 2012), liposomes (Allen & Cullis 2013), cyclodextrins 
(Irie 1999), and polymeric particles (Mora-Huertas et al. 2010). In addition to solubilizing 
hydrophobic compounds, HAs have surfactant characteristics, which makes them a potential 
new technology for cosmetic and drug delivery. Few studies in the literature have reported the 
use of HAs as an alternative means of solubilizing, loading, and consequently enhancing the 
bioavailability of hydrophobics. Such studies will be discussed further below. 
 
3.3. Binding cationic metals 
The ability of HAs to bind cationic metals and form complexes makes them useful in 
various applications, such as the transport of micronutrients from the soil to plants (Chen & 
Stevenson 1986), the removal of heavy metals from soil and water (Yates & von Wandruszka 
1999), the inhibition of the formation of free radicals by metal catalysis (Rice-Evans et al. 
1997), reduction, and stabilization of metal nanoparticles (Litvin & Minaev 2013). 
The role of metal ions in solution is the same as that of H+ ions, namely, charge 
neutralization, and the higher the charge, the more effectiveness the cation is in the formation 
of pseudomicelles. Furthermore, multivalent cations interact with phenolic and carboxylic 
groups on adjacent chains, enhancing pseudomicellar domains and the detergent effect. The 
mechanism of this interaction proposed by von Wandruszka (2000) is as follows. The 
interaction between HAs molecules and metal cations is initially entirely electrostatic, and the 
cations move to their thermodynamically preferred locations within the structure. This process 
forms spherical HAs-metal complexes, as shown in Figure 3.1.4. Studies on HAs-metal binding 
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have shown that this interaction varies according to the metal and is influenced by the metal 
concentration and the origin, molecular weight, and concentration of HAs (Christl et al. 2001; 
Yates & von Wandruszka 1999). 
 
Figure 3.1.4. Interaction of Mg2+ ions with an HA molecule and its folding around the hydrophobic 
region. Figure adapted with permission from Engebretson & Wandruszka (1994) Copyright 
American Chemical Society. 
 Christl et al. (2001) demonstrated that the binding capacity between HAs and metals is 
associated with the molecular size of HAs. 13C NMR analysis verified that HAs fractions with 
lower molecular weight have the highest number of phenolic and carboxylic groups and are 
therefore the fractions that can bind metals most efficiently. In another work, Christl & 
Kretzschmar (2001) observed that higher concentrations of metal could improve the 
effectiveness of the interaction. At high concentrations of Cu2+, the binding capacity of HAs 
was improved, especially in smaller molecules. In the same work, protonation assays were 
performed using Cu2+, and the H+/Cu2+ exchange ratios of HAs suggested that Cu and HAs bind 
as monodentate and bidentate complexes. However, these characteristics vary according to the 
metal being complexed. 
Yates & von Wandruszka (1999) verified the affinity of leonardite HAs with different 
metals by retention in an HAs-packed column, finding that Pb2+ and Cu2+ had the greatest 
affinity for the column and that Mg2+ had the lowest. The low retention of Mg2+ is attributed to 
the low availability of HAs sites to this ion because of its large radius, which is the largest 
among the cations tested. 
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The ability of HAs to bind metals and form complexes, enabling their use as a pollution 
remedy by removing heavy metals from water and soil, is a fairly recent topic in the literature 
(De la Rosa et al. 2011; Kalina et al. 2013; Stathi & Deligiannakis 2010; Wang et al. 2011). 
However, if the environment is acidic, which is typical of metal-polluted water, the solubility 
of HAs is reduced, which interferes in the formation of HAs-metal complexes. 
4. Role in human health  
Relative to their applications in agriculture and pollution treatment, there are few 
discussions of the use of HAs for the benefit of human health and wellness in the literature. In 
the following section, we will consider the effects and mechanisms of HAs in medical, 
pharmaceutical and cosmetic contexts as well as their toxicity to the human organism.  
 
4.1. Medicine 
Several works in the literature have studied the medicinal properties of HAs, which have 
been reported to be strong allies in the treatment of many diseases. The antiviral activity of HAs 
was observed against many viruses, such as cytomegalovirus (CMV), vaccine viruses, and 
human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) (Klöcking & Helbig 2005; 
Neyts et al. 1992; Schols et al. 1991). HAs molecules, which assume a negative charge in 
neutral to basic media, can inhibit virus replication by binding cationic domains of the virus, 
which are necessary for virus attachment to the cell surface (Neyts et al. 1992). The anti-HIV 
activity of these substances was demonstrated through inhibition of the infectivity of in vitro 
human lymphocytes, in addition to blocking the formation of syncytia between infected and 
non-infected lymphocytes (Zanetti 1995). van Resburg & Naude (2009) have demonstrated that 
potassium humate inhibits the production of inflammatory cytokines (TNF-α, IL-1β and IL-6) 
due to the binding properties of HSs, and Junek et al. (2009) have shown the bimodal effect of 
HAs on (LPS)-induced TNF-α release in human U937 cells. TNF-α is a cytokine with an 
important protective role against microbial effects, but at high levels, it is associated with many 
inflammatory diseases (Bahri et al. 2007; Kim & Remick 2007). It was shown that at low 
concentrations of HAs, the TNF-α release is enhanced (pro-inflammatory effect), whereas at 
high concentrations (> 100 µg ml-1), the release is reduced approximately 10-fold (anti-
inflammatory effect). The authors attributed the bimodal effect of HAs to the presence of 
negatively charged functional groups because it is known that other polyanionic compounds 
induce changes in cytokine production.  
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HAs are also recognized as inhibitors of mutagenesis, possessing an antimutagenic 
activity that blocks the mutagenesis process inside the cell and a desmutagenic activity that 
inhibits mutagenesis outside the cell (Sato et al. 1986). Ferrara et al. (2006) have investigated 
the capacity of HAs to reduce the mutagenicity of mitomycin C (MMC) in the human 
lymphoblastoid cell line TK6. A significant desmutagenic activity in cells treated with a 
combination of HAs (leonardite and soil HAs) was verified by the induction of micronuclei 
(MN), whereas the antimutagenic activity was observed in a more limited way. In both cases, 
higher efficiency was observed at higher HAs concentrations, and the results varied with the 
type of HAs used. The authors related the biological activity to the concentration and 
composition of HAs, which changes according to the origin, age, and biological conditions of 
the HAs, as already mentioned.  
Prion diseases are a group of neuropathies caused by a conformational modification in 
the structure of prion proteins (PrP). Normal PrP (PrPC) are induced by a modified protein 
(PrPSC) that changes their conformation from α­helical motifs to β­sheet secondary structures 
through a posttranslational process (S.B. Prusiner 1998). In Legname et al. (2011), it was found 
that HAs could eliminate PrPSC infectivity from chronically infected living cells. The 
mechanism proposed by the authors is direct binding between HAs and PrPC blocking the 
conversion reaction from the normal PrP to the misfolded one. 
The ability of HAs to bind metals was explored in medicine in a study by Litvin & 
Minaev (2013). The group synthetized silver nanoparticles (AgNPs) coated with synthetic HAs 
by electrostatic interactions to obtain a combination of biologically active nanoparticles for 
medical applications. It was verified that HAs were able to stabilize AgNPs via their repulsive 
forces for a long period of time (1 year). In addition, the antibacterial abilities of HAs enhance 
this effect on the AgNPs, suggesting that these conjugated nanoparticles have great potential in 
the preparation of pharmaceuticals.  
HAs can have a positive effect on wound healing and cancer therapy, as suggested by 
Jurcsik (1994). The healing process requires extra oxygen, and this demand appears in the first 
minute after wounding due to phagocytosis, the main event in wound healing process, which is 
very oxygen-consumptive (Jurcsik 1994). Semiquinones are able to produce ROS through 
different mechanisms, as shown in Figure 3.1.5. In the presence of molecular oxygen, 
semiquinones produce superoxide ions, which are converted to hydrogen peroxide in the 
presence of superoxide dismutase. The superoxide ions produce hydroxyl radicals by reacting 
with transition metals (Fenton reaction) or hydrogen peroxide (Haber-Weiss reaction). 
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Figure 3.1.5. Redox cycle of quinone. 
Quinones are widely studied in cancer therapy because ROS cause oxidative stress and 
induce apoptosis in cancer cells through DNA fragmentation and can also act as an intracellular 
signal of the apoptosis cascade. Moreover, quinones directly interfere in the apoptosis of normal 
and cancer cells in a concentration-dependent manner (Endo et al. 2014; Müller et al. 1997; 
Morales et al. 2013; Pan et al. 2000; Sagar & Green 2009).  
4.2. Pharmaceutical and cosmetic areas 
Although studies involving HAs in pharmaceutical and cosmetics applications remain 
scarce, the results note the potential of HAs as functional agents in the prevention or treatment 
of various diseases.  
HAs in natura may be used in sunscreen, anti-aging, and skin care products in general 
due to their ability to absorb in the UV-visible range. Klöcking et al. (2013) studied the potential 
of HAs as a component of lipsticks to prevent the reactivation of the herpes simplex virus by 
UV-light. It was shown that HAs in concentrations higher than 100 µg ml-1 were able to protect 
U937 cells from UV-induced damage. These characteristics make HAs viable as components 
of functional lipsticks. 
The antiviral activity of HAs could also be explored in cosmetics as a component of 
facial masks, which are used for the prevention of viral reactivation after a chemical facial 
treatment, as described by Wollina (2009).  
The phenolic groups in HAs act as electron-donating agents, scavenging free radicals 
and preventing chain reaction initiation. In addition, they are able to chelate metals, particularly 
iron and cooper, inhibiting the formation of free radicals by transition metal catalysis, 
controlling lipid peroxidation and DNA fragmentation (Aeschbacher et al. 2012; Khil’ko et al. 
2011). These antioxidant properties are also useful in cosmetic and pharmaceutical applications.  
-
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Khil’ko et al. (2011) have evaluated the antioxidant capacity of HAs from brown coal 
through their behavior in inhibiting radical-chain oxidation process of cumene and 
ethylbenzene initiated by azobisisobutyronitrile (AIBN) and dimethyl sulfoxide (DMSO). It 
was verified that the rate of oxygen absorption decreased significantly in the presence of HAs, 
and at high concentrations (10 g L-1), the oxidation process was completely halted. Adam & 
Needham suggested the use of HAs derivatives as natural antioxidants for food preservatives 
but with potential use for a variety of purposes, such as in cosmetic applications and as 
nutritional supplements. These derivatives were obtained by reductive cleavage techniques and 
were more efficient and cost effective than other food antioxidants. 
Indirectly, HAs could act as solubilizing agents, carrying pharmaceutical and cosmetic 
active ingredients in their micelle-like structures to enhance their water solubility. 
Carbamazepine (CBZ) is an antiepileptic drug that is practically insoluble in water and therefore 
has a poor bioavailability. Mirza et al. (2011) evaluated the water solubility, release, and 
anticonvulsant activity of CBZ complexed with HAs. The solubility of the complex was greatly 
increased compared to that of the free drug and that of the drug release conducted in a dialysis 
bag. The anticonvulsant activity was studied in mice using the maximum electroshock seizure 
(MES) experiment, and the potency of CBZ-HAs was threefold higher than that of the free 
drug. 
Complexes of β-carotene and HAs were synthesized by Martini et al. (2010) to increase 
β-carotene water solubility. These carotenoids have important biological activities, including 
antioxidant properties and as a precursor of vitamin A, but their hydrophobicity restricts their 
use in the pharmaceutical, cosmetic, and food fields. The authors showed that the water 
solubility of β-carotene was strongly increased by complexation to HAs, and its stability 
towards light irradiation was improved by approximately 60%.  
Ghosal (2003) and Khanna et al. (2010) developed delivery systems from HS for active 
ingredients (pharmaceutical, nutritional, and cosmetic) with low solubility. The systems 
consisted of complexes between HS and drugs produced by hydrophobic bonding, covalent 
bonding, or chelation. These systems were capable of increasing drug solubility, permeability, 
and bioavailability and were suitable for topical or oral administration. Therefore, HAs are a 
promising matrix for the incorporation of bioactive ingredients in nano- or microstructures. 
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4.3. Toxicity 
HAs toxicity is recognized as being remarkably low (Czyzewska-Szafran et al. 1993; 
Riede et al. 1992; Thiel et al. 1981). Dermal tests conducted on both rats and rabbits revealed 
no abnormalities in acute or chronic toxicity studies with HS preparations, and no local irritancy 
was observed (Czyzewska-Szafran et al. 1993). The effects of ocular irritation caused by HAs 
were also evaluated by Hen’s Egg Test-Chorion Allantoic Membrane (HET-CAM) testing by 
Wiegleb et al. (Wiegleb et al. 1993), and irritation in mucous membranes and skin was not 
detectable at HAs concentrations up to 10%. Sato et al. (1986) conducted mutagenic tests using 
Salmonella typhimurium TA100 and TA98, and mutagenic effects were not observed for HAs 
preparations.  
Nonetheless, the ROS present in HAs could mediate toxicity at certain concentrations 
(Fridovics 1978; Qi et al. 2008). Some works in the literature have reported HAs as being toxic 
to many mammalian cells (Lee et al. 2009; Lu et al. 2006; Yang et al. 2004) and contributing 
to Blackfoot disease (Cheng et al. 1999); both of these activities are related to ROS.  
Nevertheless, the phenolic portions of HAs are able to slow the oxidative transformation 
of quinones (Aeschbacher et al. 2012). HAs have a “buffering effect”, which means that they 
are able to produce and to bind ROS (Jurcsik 1994). This finding is in agreement with the view 
that HAs have great potential as natural antioxidants despite the presence of quinone groups. 
 
5. Novel technological developments 
HAs have substantial potential to be used in pharmaceutical and cosmetics areas because 
they can act directly or indirectly in the prevention and remediation of many complications of 
the human body.  
These functional effects could be improved through the interaction of HAs with 
surfactants (Ishiguro & Koopal 2011; Matsuda et al. 2009). In previous work, we demonstrated 
that HAs were able to interact with the nonionic surfactant PF127 by amphiphilic and 
electrostatic interactions due to their amphiphilic character and their potential to assume a 
negative charge by deprotonation of the OH/OOH groups (de Melo et al. 2015). The interactions 
formed stable and spherical HA-PF127 nanoparticles with a highly hydrophobic core, which 
can be used for pharmaceutical applications as-is or after entrapping nonpolar drugs, increasing 
their water solubility and bioavailability.  
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6. Conclusions 
HAs have been widely explored for several years for their benefits in agriculture and 
pollution remediation. They are known to enhance plant growth and nutrition and act as soil 
bactericidal and plant fungicidal agents, and they can be used to remove pollutants from water 
and soil. In medicine, they can act as antiviral and anti-inflammatory agents; have uses in 
wound healing, cancer and prion disease therapy; and exhibit antimutagenic/desmutagenic 
potential. In pharmaceutical and cosmetic areas, the use of HAs is recent but very promising. 
They are known to protect against UV-vis radiation and can act as antioxidants. Further 
applications include their use as solubilizing agents and for transporting hydrophobic active 
compounds, two applications that may be improved by their administration as HAs-surfactant 
nanoparticles. This novel technology will enable the production of stable HAs nanoparticles, 
with a large hydrophobic core that could be used for the encapsulation of nonpolar drugs, 
improving their delivery and bioavailability. 
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4. RESULTADOS E DISCUSSÃO 
Esta seção será apresentada na forma de capítulos contendo os artigos científicos 
referentes aos resultados desta pesquisa 
O primeiro artigo apresentado, The interactions between humic acids and Pluronic F127 
produce nanoparticles useful for pharmaceutical applications, trata do estudo das interações 
entre AHs e PF127. Neste estudo variou-se a razão molar AH/PF127 visando-se obter as 
melhores condições para a produção de nanopartículas de AH-PF127, além da caracterização 
dos AHs Sigma-Aldrich. O trabalho teve como objetivo a produção de nanopartículas de AHs 
com propriedades adequadas para serem utilizadas em aplicações farmacêuticas.  
O segundo artigo, The effects of Pluronic F127 on membrane permeation, curcumin 
entrapment and antioxidant activity of humic acids nanoparticles, trata da aplicação das 
nanopartículas produzidas conforme apresentado no primeiro artigo. Nesse trabalho, foi 
estudada a capacidade das nanopartículas AH-PF127 de permear membranas de policarbonato 
de 30 nm, simulando sua permeação pelos poros da pele, visando sua possível aplicação tópica. 
Além disso, a capacidade as partículas de encapsular fármacos hidrofóbicos foi verificada 
utilizando-se a curcumina. A atividade antioxidante das AH-PF127 foi estudada através dos 
métodos de sequestro dos radicais livres ABTS e DPPH. O trabalho teve como objetivo o estudo 
da capacidade de aplicação tópica farmacêutica das nanopartículas de AHs e a influência do 
PF127 no sistema. 
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4.1. The interactions between humic acids and Pluronic F127 produce 
nanoparticles useful for pharmaceutical applications 
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University of Campinas, 13083-852, Campinas, São Paulo, Brazil 
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ABSTRACT 
Humic acids (HAs) are macromolecules composed of a large variety of functional groups 
including phenols and carboxylic acids, which have anti-inflammatory and antioxidant 
properties. HAs are completely soluble in aqueous medium in alkaline conditions only. At 
neutral pH, the protonation of the OH/OOH groups causes the formation of micelle-like 
structures containing a hydrophobic core. Pluronic F127 (PF127) is a non-ionic and non-toxic 
block copolymer with surfactant properties, which are able to interact with HAs through 
hydrophobic interactions. In this work, these interactions were studied to determine the 
potential of HA-PF127 structures for pharmaceutical applications. The HAs used was 
composed of phenol (15.92%), carboxylic (13.70%) and other aromatic groups as characterized 
by 13C NMR, GC-MS and FTIR. Initially, the HA-PF127 interactions were identified by a 
fivefold decrease in the CMC of PF127. The effects of the HA:PF127 molar ratio were studied 
by adding naturally occurring HAs to PF127 dispersions under mechanical stirring. The highest 
ratios, 1:8 and 1:80, favored the formation of submicellar aggregates of approximately 100 nm 
and zeta potentials of -28.37 and -30.23 mV, respectively. HA-PF127 structures were spherical, 
with a polydispersity of approximately 0.43. These results show that the interactions between 
HAs and PF127 produce stable nanoparticles. These nanoparticles may be used as a carrier for 
hydrophobic bioactives and as an antioxidant or anti-inflammatory agent.  To the best of our 
knowledge, this work is the first attempt to develop HA-PF127 nanoparticles.  
 
Keywords: Humic acids. Pluronic F127. Nanoparticles. Pharmaceutical Application.  
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1. Introduction  
Humic substances (HS) are organic matter originated from the decay of vegetable and 
natural residues in terrestrial soil, natural water and sediment (Maccarthy 2001). HS are 
comprised by three different fractions: humins, fulvic acids and humic acids (HAs).  
HAs are macromolecules with undefined chemical compositions that vary with the 
origin and conditions of their extraction/production. HAs contain numerous functional groups 
including carboxylic acid, phenol, enol, alcohol, quinone, ether and others (Sposito 1986; 
Stevenson 1982). The OH groups correspond to the hydrophilic portions of HAs, while the 
aromatic rings and aliphatic chains contribute to their hydrophobic character and give rise to 
surfactant properties.   
The OH/OOH groups in HAs structure are responsible for various properties of these 
organic acids that are beneficial to human health. When deprotonated, HAs are able to bind 
cationic sites of a virus, thus inhibiting the virus’ attachment to the cell surface and preventing 
its replication (Neyts et al. 1992). This characteristic is also related to their anti-inflammatory 
(Junek et al. 2009) and antimutagenic/desmutagenic effects (Ferrara et al. 2006). HAs have 
many phenolic groups in their structure, which provide antioxidant characteristics. Phenols act 
as electron donators, scavenging free radicals, preventing chain reactions and binding metals 
such as iron and copper, therefore inhibiting free radical formation by metal catalysis (Rice-
Evans et al. 1997). HAs can also absorb in the UV-visible range and, thus, have potential for 
use in sunscreens, anti-aging creams and skin care products in general (Klöcking et al. 2013). 
In addition to these inherent properties, HAs can complex with hydrophobic compounds, 
making them soluble in water (Martini et al. 2010). 
HAs do not have a defined composition. They are distinguished from the other HS 
fractions based on water solubility, defined as being in neutral-to-alkaline conditions 
(Stevenson 1982). In addition to pH, the presence of cations in the medium can affect HAs 
solubility (Von Wandruszka et al. 1997). In alkaline mediums, HAs are completely soluble 
because the OH groups are deprotonated, and the repulsion of these negatively-charged groups 
causes the molecules to assume a stretched configuration. With a decrease in pH or the addition 
of cations to a solution, these negatively-charged groups are re-protonated, and the charge 
repulsion is minimized. This change causes the molecules to coil up and aggregate to form 
compact structures called pseudomicelles with hydrophobic cores and hydrophilic surfaces 
(Von Wandruszka et al. 1997; Von Wandruszca 2000). In water, HAs have both soluble and 
insoluble fractions. According to the mechanisms proposed by Klučáková & Pekař (2005), the 
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soluble fractions of HAs can exist as dissolved molecules and in a dissociated form, while the 
insoluble fractions can interact with the environment by acting like an ion-exchanger and 
releasing H+ ions into solution, while the anions remain insoluble.  
As amphiphilic molecules, HAs interact with surfactants through hydrophobic and 
electrostatic interactions (Ishiguro & Koopal 2011; Matsuda et al. 2009; Otto et al. 2003). Otto 
et al. (2003) demonstrated that HAs decreased twofold the CMC of sodium dodecyl sulfate 
(SDS), an anionic surfactant, suggesting the formation of submicellar HA-SDS aggregates. 
Even with the electrostatic repulsion between the two compounds, the hydrophobic interaction 
was more significant. To our knowledge, no report exists describing interactions between HAs 
and surfactants for use in pharmaceutical applications.  
Pluronic F127 (PF127) is a nonionic surfactant that belongs to the block copolymers 
group, formed by the triblock structure PEO-PPO-PEO. In this triblock, PEO is poly(ethylene 
oxide) (the hydrophilic portion), and PPO is poly(propylene oxide) (the hydrophobic portion). 
Among all the block copolymers, PF127 is one of the least toxic, and has therefore been used 
for wound and burn healing/treatment for many years (Schmolka 1972). PF127’s low toxicity 
and high biocompatibility make this surfactant appealing for use as a drug carrier (Foster et al. 
2009; Taha et al. 2014). Several previous studies demonstrated that the interaction of PF127 
with other surfactants enhances its stability and the permeation and diffusion properties of the 
active compounds (Antunes et al. 2011; Zhang et al. 2011).  
In this work, we studied HA-PF127 interactions with the potential for the technological 
production of nanoparticles, which are useful alone or as a drug delivery system, for 
pharmaceutical.  
 
2. Materials and Methods 
2.1. Materials 
Both commercial HAs and PF127 were purchased from Sigma-Aldrich (Switzerland). 
Ultrapure water was used throughout all experimental studies. 
 
2.2. Characterization of solid HAs 
2.2.1. Elemental analysis  
Carbon, nitrogen, hydrogen and sulfur content were determined quantitatively by 
combustion bulk elemental analysis using a Fisons-EA-1108 (Thermo Scientific, MA, USA). 
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2.2.2. Solid state 13C NMR spectroscopy 
Solid-state 13C NMR spectra of HAs were obtained using the high-powered decoupling 
program (HPDEC) on a Bruker 400 resonating at 100 MHz. The spinning rate was maintained 
at 10 kHz using a 4 mm Zr rotor. 
 
2.2.3. Pyrolysis-gas chromatography-mass spectroscopy 
The pyrolysis of HAs was performed in a muffle furnace at 650 °C for 10 minutes. 
Vapors generated during the heating were collected with dichloromethane, and the extracted 
vapors were analyzed using an Agilent 5975C single quadrupole GC-MS with a He flow gas 
and a HP-5 MS 5% diphenyl and 95% dimethylpolysiloxane column (30 m x 0.25 mm x 0.25 
µm) was employed in the separation. NIST11 Standard Reference Database were used to 
identify the compounds detected. 
 
2.2.4. Fourier transform infrared (FTIR) analysis 
FTIR analysis of solid HAs was performed on a Thermo Scientific Nicolet 6700 
spectrophotometer. Pellets were prepared by mixing 2 mg of solid HAs with 200 mg of KBr 
and pressing the mixture under vacuum at 7 t for 10 minutes. The wavelength range of the 
performance was 4000-400 cm-1 with a resolution of 4 cm-1. 
 
2.3. Interactions between PF127 and HAs 
2.3.1. Critical micelle concentration (CMC) 
CMC values of PF127 and HA-PF127 were determined using conductivity 
measurements in a conductivimeter Digimed DM-32 at room temperature. The PF127 
dispersions were prepared at a concentration between 50 and 3,000 mg L-1 (0.005 and 0.30%) 
under magnetic stirring.  For HA-PF127 assays, 10 mg L-1 of solid HAs were added to the 
PF127 dispersions under mechanical stirring at 700 rpm and 25 ºC for 1 hour. Next, the 
solutions were filtered with 80 g qualitative filter paper to remove the precipitated HAs. The 
final concentration of the dispersed HAs was 6 mg L-1. The assays were performed in triplicate. 
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2.3.2. Preparation of HA-PF127 nanoparticles 
Dispersions of PF127 were prepared at the following concentrations: 0.1, 1.0 and 5.0% 
w/v. Solid HAs were added to the PF127 dispersions under mechanical stirring at 700 rpm and 
25ºC for 1 hour. Then, the formed dispersions were filtered with 80 g qualitative filter paper to 
remove the precipitated HAs. The precipitated fraction contained approximately 40% of the 
HA initial mass. Thus, solutions with molar ratios of 1:80, 1:800, and 1:4000 HAs:PF127 were 
made from 6 mg L-1 HAs (10 mg L-1 initial HAs). The highest molar ratio (1:8) was made from 
adding 55 mg L-1 HAs (100 mg L-1 initial HAs) to a 0.1% PF127 dispersion. A solution of 10 
mg L-1 HAs in water and solutions of 0.1, 1.0 and 5.0% w/v PF127 without HAs were used as 
controls.  The assays were performed in triplicate. 
 
2.4. Characterization of the HA-PF127 nanoparticles 
2.4.1.  Size, polydispersity index (PDI) and zeta potential  
The size, polydispersity index and zeta potential of HA-PF127, PF127 and HAs 
structures were measured using dynamic light scattering (DLS) in an Autosizer 4700, Zetasizer 
Nano (Malvern).  The equipment measured each sample ten times.  
 
2.4.2. Scanning electron microscopy 
The morphology of the HA-PF nanoparticles (1:80 molar ratio) was verified by scanning 
electron microscopy (SEM) after drying the sample and coating it with 1.5 nm of iridium. The 
analysis was carried out using a Quanta FEG 250 microscope operating at an accelerating 
voltage of 20 kV.   
 
3. Results and Discussion 
3.1. Characterization of solid HAs 
Due to the variability in HAs composition based on its origin/extraction process, it was 
necessary to characterize the compound being used in this work. The CNHS elemental analysis 
of the HAs used in this work provided the following results: 38.13% of C, 3.21% of H, 0.66% 
of N and 0.36% of S. Oxygen and inorganic constituents composed the remainder of the 
compound. The results differed from previous studies on HAs from Sigma-Aldrich (Sidiqui et 
al. 2009), especially in carbon concentration, which the authors characterized as being 55.60% 
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of the total HA composition. This difference could be due to different sources of extraction or 
different purity levels of the compound, which were not specified by the supplier.  
The functional groups were characterized by solid-state 13C NMR spectroscopy and 
pyrolysis GC-MS to identify the presence of OH and COOH, which gives HAs its 
pharmaceutical properties. The 13C NMR spectra of the HAs presented in Figure 4.1.1A exhibits 
peaks corresponding to the chemical shifts of 13C from the aliphatic, aromatic, carboxylic and 
thiocarbonyl groups in accordance with reports by Pretsch et al. (2000). The presence of 
aliphatic groups was confirmed by the signal between δ 50-0 ppm, while the presence of 
aromatic groups was indicated by an intense signal between δ 160-100 ppm. The shoulder in δ 
150 ppm indicates the presence of a phenolic group. The signal between δ 190-160 ppm 
corresponds to the presence of carboxylic groups in the HAs. There exists a less intense signal 
in the range of δ 240-220 ppm that likely corresponds to the thiocarbonyl groups. The resonance 
integrals of the four peaks are shown in Table 4.1.1. Their content was calculated as the sum of 
the percentages of the peak area for each compound. Aromatic groups corresponded to 56.18% 
of the total composition, including phenolic groups, because it was not possible to integrate 
these groups separately. The aliphatic and carboxylic acids corresponded to 24.77% and 
13.70% of the total composition, respectively, and the thiocarbonyls corresponded to 5.35% of 
total peak area.  
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Fig. 4.1.1. Characterization of HAs used in this study. 13C NMR spectrum (A). The chromatogram of GC-MS of 
the pyrolyzed extract of the HAs (B). FTIR spectrum (C). 
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Table 4.1.1. Relative intensity distribution and chemical shift of the functional groups in the 13C NMR spectra of 
the HA used in this study. 
Functional group 
Chemical shift 
(ppm) 
Relative intensity (%) 
Thiocarbonyl 240-220 5.35 
Carboxylic Acid 190-160 13.70 
Aromatic 160-100 56.18 
Aliphatic 50-0 24.77 
 
The GC-MS chromatogram of the pyrolyzed extract of HAs is shown in Figure 4.1.1B. 
Fifteen peaks were identified, and all of the compounds are listed in Table 4.1.2. Their content 
was calculated as the sum of the percentages of the peak area for each compound. The 
carboxylic acids have not been identified because of their thermal degradation in CO2 during 
the pyrolysis process. The phenolic groups corresponded to 15.92% of the total composition, 
while all other aromatics corresponded to 82.05% of the total composition. The analysis showed 
that the aliphatic groups correspond to 2.03% of the total composition. The high content of 
alkylbenzenes and the low content of aliphatic groups characterized by GC-MS, could be 
explained by thermal degradation of aromatic rings linked to aliphatic chains, which forms 
aromatic hydrocarbons (Abbt-Braum et al. 1989; Schulten 1987). 
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Table 4.1.2. Time retention, abundance and the base m/z of the compounds obtained by pyrolysis-GC/MS of the 
HAs used in this study. 
Compound Rt (min) Abundance (%) Base m/z 
Toluene 4.58 38.42 91 
Dimethylhexane 5.41 2.03 57, 114 
Ethylbenzene 7.19 5.92 91, 106 
Xylene (isomer) 7.43 14.27 91, 106 
Xylene (isomer) 8.16 5.66 91, 106 
Methyl-ethylbenzene (isomer) 10.40 2.13 105, 120 
Methyl-ethylbenzene (isomer) 10.44 1.88 105, 120 
Phenol 11.13 11.05 66, 94 
Trimethylbenzene (isomer) 11.42 2.90 105, 120 
Trimethylbenzene (isomer) 12.34 2.46 105, 120 
Methylphenol 13.45 2.76 79, 90, 108 
Cresol 14.11 2.11 77, 91, 108 
Naphtalene 17.31 4.04 102, 128 
Methylnaphtalene (isomer) 20.47 2.85 115, 141 
Methylnaphtalene (isomer) 10.93 1.45 115, 141 
Figure 4.1.1C shows the FTIR spectrum of solid HAs and was interpreted based on 
Günzler & Gremlich (2002). The presence of aliphatics was evidenced by two stretching bands 
of C-H at 2917 and 2848 cm-1 and two bending bands at 1380 (in plane) and 1030 cm-1 (out of 
plane). The band at 1030 cm-1 could also be attributed to C=S stretching of the thiocarbonyls. 
At 1615 cm-1, we observed a pronounced peak from 1500 to 1800 cm-1. Aromatic C=C and 
C=O stretching bands appear at 1615 cm-1; the shoulder at 1700 cm-1 may be a result of C=O 
stretching of carboxylic acids or ketones. As ketones were not identified by the other two 
methods of characterization, we attributed this shoulder to the presence of carboxylic acids. 
Carboxylic acids may also account for the stretching vibration bands of C-O in 1093-1030 cm-
1 region and the bending of C-O-H in plane at 1380 cm-1. The C-C vibration in aromatics 
appears from 1600-1585 cm-1 and at 690 cm-1, and the peak at 912 cm-1 corresponds to the C-
H deformation in these groups. The hydroxyl stretching bands (3691-3436 cm-1) could be a 
result of phenolic and carboxylic acids present in the compound.  
The three methods of characterization were complementary to each other. The FTIR 
spectrum contained a large peak corresponding to C=C and C=O stretching bands of aromatic 
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and phenolic/carboxylic groups, because neither 13C NMR nor GC-MS indicated the presence 
of ketones in HAs. The low-intensity peaks of aliphatics compared to aromatics in FTIR were 
in agreement with the other methods of characterization. Using 13C NMR and GC-MS, we 
determined that carboxylic acids and phenols account for 13.70 and 15.92%, respectively of the 
total HAs.  These results are in agreement with the values found in the literature for HAs from 
Sigma-Aldrich (Baigorri et al. 2009; Shin et al. 1999).  Thus, approximately 70.00% of the HAs 
is composed by hydrophobic components, which contribute to the nonpolar core of the HAs 
structures in water.  
 
3.2. Interactions between PF127 and HAs 
3.2.1. Critical Micelle Concentration (CMC)  
The interactions between PF127 and HAs were initially studied using CMC 
determinations of PF127 and HA-PF127 using electrical conductivity measurements.  The 
abrupt change in the slope marked ‘CMC’ is shown in Figure 4.1.2. The CMC value for PF127 
was 822 mg L-1 (0.082%), which was comparable with previously reported values (Sezgin et 
al. 2006; Vasilescu & Bandula 2011). The CMC for HA-PF127 was 160 mg L-1 (0.016%). In 
other words, there was a fivefold decrease in the CMC value compared with PF127 without 
HAs. After the addition of 10 mg L-1 HAs, approximately 4 mg L-1 precipitated in all assays 
(40%). Therefore, PF127 only interacted with HAs in micelle-like structures. 
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Fig. 4.1.2. CMC determinations of PF127 and HA-PF127. PF127 (A). HA-PF127 (B). 
The interactions between humic materials and surfactants were previously studied by 
Otto et al. (2003). The authors showed that the HS enhanced the aggregation of sodium dodecyl 
sulfate (SDS) prior to micellization, causing more significant hydrophobic effects. Furthermore, 
stable ion pairs were formed between the positively-charged cetyltrimethylammonium bromide 
(CTAB) and the humic substances.  
 
3.2.2.  The effects of various HA/PF127 ratio  
Figures 4.1.3 shows the Intensity (Iαd6) and Number (Nαd) distributions of 
hydrodynamic diameters obtained using light scattering for HAs, PF127 dispersions and HA-
PF127 structures as function of the initial PF127 concentration. Table 4.1.3 presents the zeta 
potential for the same samples. 
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Fig. 4.1.3. Intensity and Number distributions for hydrodynamic diameter obtained from light scattering. HAs 6 
mg L-1 (A and B). For Figures C-J: PF127 0.1, 1.0 and 5.0% (dashed line) and HA-PF127 (thick line). Ratio 
HA:PF127 (mol/mol) 1:80 (C and D). 1:800 (E and F). 1:4000 (G and H). 1:8 (I and J). The data represent the 
average measurements (10 measures) for each triplicate assay. 
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Table 4.1.3. Zeta potential of HAs, PF127 dispersions at concentrations 0.1, 1.0 and 5.0% w/v and HA-PF127 
for the different ratios HA:PF127. 
Structure Zeta Potential (mV) 
HAs   
6 mg L-1 -3.25 ± 0.71 
55 mg L-1 -32.03 ± 5.29 
PF127 in water  
0.1% -3.71 ± 1.00 
 1.0% -6.02 ± 0.64 
 5.0% -3.96 ± 1.61 
  HA:PF127 ratio (mol:mol)  
1:8 -28.37 ± 6.17 
1:80 -30.23 ± 3.88 
1:800 -15.52 ± 3.69 
1:4000 -4.68 ± 1.97 
 
Figures 4.1.3A and 4.1.3B correspond to the HAs micelle-like structures formed in 
water. The distribution of the diameter ranged from approximately 100 to 1,000 nm, with a 
maximum at approximately 300 nm. In addition, a small population of micelle-like structures 
with a diameter of approximately 10,000 nm was also detected. From the Iαd6, the calculated 
predominant mean diameter was 342 nm, according to the Nαd.  
Figure 4.1.3C shows the diameters of PF127 0.1% micelles ranged from 10 to 100 nm. 
The presence of HAs in the 1:80 ratio of HA:PF127 greatly reduced the peak at approximately 
10 nm and slightly shifted the peak of HA pseudomicelles from 100-1,000 nm to 100-500 nm, 
suggesting the formation of mixed micelles with PF127. However, the Nαd (Figure 4.1.3D) 
shows that 5 nm PF127 micelles predominate in the dispersion. Figures 4.1.3E and 4.1.3F 
suggest a slight incorporation of PF127 in HA micelle-like structures in the 1:800 ratio, forming 
HA-PF127 structures with sizes ranging from 100 to 600 nm and the predominance of 5 nm 
PF127 micelles in the dispersion. At the ratio 1:4000 (Figures 4.1.3G and 4.1.3H), the Iαd6 
peaks corresponding to surfactant micelles were maintained or suffered only minor changes, 
while populations with large diameters appeared throughout the range of 100 to 10,000 nm. In 
this experiment, higher surfactant concentrations may have induced the formation of 
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intermolecular bonds without interacting with the HA micelle-like structures. Similar to 
experiments with ratios of 1:80 and 1:800, the Nαd suggests that the main population in the 
dispersion consists of PF127 micelles.  
Finally, Figures 4.1.3I and 4.1.3J represent the highest HA-PF127 ratio (1:8). The Iαd6 
suggests a decrease in the number of PF127 micelles and the incorporation of the surfactant in 
HA pseudomicelles. This may be due to hydrophobic interactions between the aromatic groups 
in HAs and the PPO from the surfactant. The Nαd shows that for this ratio, the predominant 
population in the dispersion consists of HA-PF127 structures with a diameter of approximately 
100 nm. These results suggest that interactions between HAs and PF127 may reinforce tight 
packing and form a cohesive core in HA-PF127 structures (Lee et al. 2011; Manaspon et al. 
2012). With a more hydrophobic core, these nanoparticles will be more likely to entrap nonpolar 
bioactive compounds (Owen et al. 2012; Wei et al. 2009). 
In addition to the diameter distributions, the presence of HAs increased the 
polydispersity of the PF127 micelles from values of approximately 0.27 to 0.43 at 0.1 and 1.0%, 
confirming the described interactions.  
Table 4.1.3 shows the results from zeta potential analysis. Slightly negatives values (-
3.25 mV) were measured for HAs at 6 mg L-1 and higher values (-32.03 mV) for HAs at 55 mg 
L-1, indicating a direct effect on zeta potential that is likely due to the presence of OH-/OOH- 
groups. Slightly negative values were measured for PF127 micelles that indicated low stability 
of the dispersions, which are prone to aggregation. The addition of HAs in the PF127 
dispersions in ratios of 1:8, 1:80 and 1:800 results in  high negative values of zeta potential of 
-28.37, -30.23 and -15.52 mV, respectively. This indicates that the surfactant interacts with HAs 
pseudomicelles as shown in Figure 4.1.4 and that the zeta potential value may be exclusively 
affected by HAs. At the lowest ratio (1:4000), the zeta potential value corresponds to the micelle 
structures of PF127 due to their excess in the dispersion. 
Figure 4.1.4 illustrates the probable interaction between HAs and PF127 in HA-PF127 
structures. Initially, PF127 self-assembles into micelles because it is above its CMC. The 
soluble fraction of HAs in aqueous solution undergoes intermolecular disaggregation due to the 
charge repulsion caused by the deprotonation of some of the OH/OOH groups at neutral pH 
(Kluĉáková & Pekař 2005; Von Wandruszka et al. 1997; Von Wandruszka 2000). The non-
stable micelles of PF127 in water interact with HAs mainly through hydrophobic interactions, 
as previously reported for hydrophobic drugs (Lee et al. 2011; Zhang et al. 2011). These 
hydrophobic interactions contributed to the larger and more hydrophobic core of HA-PF127 
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than HAs alone, which may enhance their ability to entrap nonpolar drugs and to act as a novel 
alternative to existing nanoparticles for drug delivery.  
A synergistic effect could be achieved from the encapsulation of drugs that have effects 
found in HAs, such as antioxidant and anti-inflammatory activity. It is expected that HAs could 
enhance these activities and result in lowering the required concentration of administered drugs.  
 
Fig. 4.1.4. Schematic illustration of the interaction between PF127 micelles and HAs micelle-like 
structures, and the formation of HA-PF127 nanoparticles. 
Figure 4.1.5 shows the morphology of the HA-PF127 structures for the molar ratio of 
1:80 obtained via SEM.  The images show non-aggregated spherical structures, with diameters 
of approximately 70-100 nm, corresponding to the presence of HA-PF127 structures in 
equilibrium with HAs pseudomicelles and PF127 micelles. 
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Fig. 4.1.5. Scanning electron microscopy of HA-PF127 structures formed in water for the molar ratio 
HA:PF127 of 1:80.  
As expected, the sizes of HA-PF127 were higher from DLS compared with SEM 
images. This is due to the fact DLS measure hydrodynamic diameters, which are greater than 
the actual diameters of the particles (Sokolova et al. 2011).  
Together, these results show that the HA-PF127 structures are electrostatically stable 
nanoparticles. They could potentially act as antioxidant or anti-inflammatory agents and entrap 
hydrophobic bioactive compounds in their cohesive core.  
 
 
4. Conclusions 
The 13C NMR, GC-MS and FTIR analysis showed that phenols and carboxylic groups 
were present in the HAs used in this work, indicating their potential to act as antioxidant and 
anti-inflammatory agents. The interactions between the HAs and PF127 were more favorable 
when higher HA:PF127 ratios were used and produced spherical and electrostatically stable 
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nanoparticles with a hydrophobic core. The results showed that the HA-PF127 nanoparticles 
are promising for pharmaceutical applications and for entrapping bioactive compounds.  
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ABSTRACT 
Humic acids (HAs) have a great pharmacological potential, being able to act as antioxidant 
agents due to the presence of phenolic groups and also as drug carriers due to their surfactant 
characteristics. HAs have potential to be used in topical application, and their interaction with 
a surfactant would facilitate HAs transport through the skin pores. Therefore, in this work, we 
produced HA-PF127 nanocomplex (125 nm sized) and studied their permeation through two 
30 nm pore diameter polycarbonate membranes under transepidermal pressure to simulate their 
permeation through skin pores. The potential of HA-PF127 nanoparticles to act as drug carriers 
was studied by encapsulating curcumin, and their antioxidant activity was verified using two 
spectrophotometric methods of free radical scavenging. The results showed that the interaction 
between HAs and PF127 produced spherical and stable nanoparticles, and we observed that the 
surfactant facilitated the permeation of HAs through the membranes without aggregation, being 
the size after permeation of 171 nm. The encapsulation efficiency of curcumin into HA-PF127 
was higher than into PF127 micelles but lower than into HAs alone, indicating that hydrophilic 
portions of PF127 could act as a diffusion barrier. The 2,2’-azino-bis(3-ethylbenzthiazoline-6-
sulfonic acid) (ABTS) free radical scavenging by HAs was improved in the presence of PF127. 
These results showed that HAs have potential to be used in pharmaceutical areas, such as acting 
as antioxidant agents or drug carriers for topical applications. 
 
Keywords: Humic acids; Pluronic F127; Nanoparticles; Antioxidant; Membrane permeation; 
Curcumin. 
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1. Introduction  
Humic acids (HAs) are macromolecules formed during the decomposition of organic 
matter present in different environments, such as soil, water and sediments (Maccarthy 2001). 
They are the fraction of humic substances (HS) soluble in alkaline to neutral conditions and 
insoluble in acidic pH (Kipton et al. 1992; Stevenson 1994). The presence of a large 
hydrophobic portion in HAs, composed basically of aromatic rings, and different functional 
groups such as phenol and carboxylic acids give them surfactant characteristics (Terashima, et 
al. 2004; Wershaw 1993), which may be useful in pharmaceutical applications. Approximately 
one third of the total amount of HAs is composed of phenolic and carboxylic groups, which 
varies with the origin of extraction (Baigorri et al. 2009; Shin et al.1999). These groups are 
deprotonated in basic pH, causing the structure to assume a stretched configuration. When the 
pH is decreased, they are protonated by H+ in the medium, and the molecules coil up due to 
minimization of the electrostatic repulsion (von Wandruszka et al. 1997; von Wandruszka 
2000). With this configuration, HAs form pseudomicelles with a hydrophobic core and can act 
as vehicles for drug delivery by entrapping nonpolar drugs and enhancing their solubility and 
bioavailability (Ghosal 2003; Khanna et al. 2010).  
In addition, the phenolic and carboxylic groups present in the structure of HAs are 
responsible for many pharmacological properties of this compound, including their antioxidant 
activity (Aeschbacher et al. 2012; Junek et al. 2009; Khil’ko et al. 2011). Antioxidants are 
electron or proton donators that can scavenge free radicals produced by reactive oxygen species 
(ROS), which are formed through the metabolism of O2 in animal tissue after successive 
reactions. In excess, ROS cause oxidative stress, which damages the cells, extracellular matrix, 
DNA and lipid membranes (Pouillot et al. 2011). The use of HAs as antioxidants could be a 
way to prevent oxidative stress, which is the cause of many skin diseases, such as cancer and 
aging (Campanini et al. 2013; Di Mambro & Fonseca 2005; Pouillot et al. 2011).  
The most promising route of administration of these antioxidants would be through the 
skin due to advantages over other routes, such as avoiding the first-pass metabolism, controlling 
and sustaining the drug delivery, and having potential access to local and systemic target sites 
(Brown et al. 2006; Chen et al. 2014). The biggest challenge of topical delivery is the 
permeation of drugs through skin pores and stratum corneum, which acts as a barrier and 
prevents the passage of foreign materials (Brown et al. 2006). However, Beer et al. (Beer et al. 
2003) verified that aquatic HS were able to permeate the human breast skin in a diffusion cell, 
and by HPLC analysis, they observed that the fractions of HS before permeation were similar 
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to the fractions after permeation. Several works in the literature evaluated the effectiveness of 
thermal mud-packs for the treatment of osteoarthritis (Cozzi et al. 1993; Pizzorno & Murray 
2012; Vaht et al. 2008; Van Rensburg et al. 2010). In these works, it was verified that contact 
of the mud with the skin reduced the pain symptoms and also increased the potentiation of 
antioxidant defenses in patients (Bellometti et al. 1997). As HAs are part of the mud 
composition (Ubner et al. 2004), their permeation through the skin may have contributed to the 
effectiveness of these mud-pack treatments. 
Although these studies have demonstrated that HAs may permeate the skin, their 
interaction with a surfactant could further improve this characteristic by making them more 
flexible. Pluronic F127 (PF127) is a nonionic and nontoxic surfactant, with hydrophobic and 
hydrophilic portions composed by poly(oxypropylene) (PPO) and poly(oxyethylene) (PEO), 
respectively, widely used in pharmaceutical applications, especially as drug carriers (Akash & 
Rehman 2015; Gilbert et al. 1986; Taha et al. 2014). Choi et al. (Choi et al. 2012) verified that 
PF127-based nanoparticles enhanced in vitro permeation of hydrophilic proteins and insulin 
through the human skin. Flufenamic acid (FFA) is a potent anti-inflammatory drug and its 
incorporation into PF127 micelles enhanced the cumulative amount of the drug after skin 
permeation by about threefold compared with FFA alone (Shazly et al. 2012).  
In previous work, our group produced HAs nanoparticles in association with PF127 
through hydrophobic interactions, forming HA-PF127 (Melo et al. 2015). In this work, we 
evaluated the ability of such nanoparticles to permeate two 30 nm polycarbonate membranes in 
order to simulate their passage through skin pores. We also verified the capacity of the 
nanoparticles to encapsulate hydrophobic drugs. For this purpose, curcumin was used, which is 
a small and very hydrophobic molecule and known for its medicinal potential, such as anti-
inflammatory, antimicrobial, anticancer, wound healing and antioxidant activities (Kant et al. 
2014; Li et al. 2015; Naksuriya et al. 2014; Siviero et al. 2015). Finally, we tested the ability of 
HA-PF127 to act as antioxidant agent by using two spectrophotometric methods: ABTS (2,2’-
azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) and DPPH (2,2-diphenyl-1-picrylhydazyl). 
 
2. Materials and Methods 
2.1. Materials 
Commercial HAs, PF127, Curcumin, ABTS, potassium persulfate (K2S2O8) and DPPH 
were purchased from Sigma-Aldrich (Switzerland). Ultrapure water was used throughout all 
experimental studies. 
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2.2. Size, polydispersity index (PDI) and zeta potential 
Size, PDI and zeta potential of the samples were measured using dynamic light 
scattering (DLS) in an Autosizer 4700, Zetasizer Nano (Malvern, UK). The equipment 
measured each sample ten times. 
 
2.3. Synthesis of HA-PF127 nanoparticles  
Solid HAs (100 µg/mL) were added to PF127 0.1% w/v and were mechanically stirred 
at 700 rpm at 25 ºC for 1 hour. Then, the insoluble fraction of HAs was filtered in an 80 g 
qualitative filter paper and its concentration was obtained by gravimetric analysis. The final 
concentration of the dispersed HAs was 55 µg/mL giving a molar ratio of HAs to PF127 of 1:8. 
55 µg/mL HAs in water and 0.1% w/v PF127 without HAs were used as control.  
 
2.4. Stability assays 
The stability of the HA-PF127 nanoparticles, PF127 and HAs were evaluated based on 
hydrodynamic diameter, PDI and zeta potential. Samples were stored at 4 ºC and protected from 
light for 6 months. 
 
2.5. Membrane permeation assay 
The membrane permeation assay was carried out in a stainless steel pressure holder, 
where HAs, PF127 and HA-PF127 were permeated through two polycarbonate membranes 
with a 30 nm pore diameter to simulate their passage through skin pores. Samples were 
subjected to 2.5 x 105 Pa of N2, which is similar to the transepidermal pressure. Size distribution, 
PDI and zeta potential were measured and compared before and after permeation.  
   
2.6. Encapsulation of curcumin in the HA-PF127 nanoparticles 
Curcumin was encapsulated into HA-PF127 by adding 100 µg/mL of curcumin solution 
in ethanol dropwise to the HA-PF127 dispersion (prepared according to Section 2.3) under 
constant stirring (800 rpm) for 10 min. The mass ratio of curcumin:nanoparticles was 1:50 
(w:w). The same procedure was followed to encapsulate curcumin in PF127 micelles and HAs 
pseudomicelles as a control. The assays was performed in triplicate. 
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The samples were left to equilibrate and after ethanol evaporation, they were filtered 
through a 0.20 µm filter to separate the non-entrapped curcumin, which was retained in the 
filter. The entrapped curcumin was estimated by measurements of absorbance at 420 nm of 
filtrate solutions. The percentage of the encapsulation efficiency (EE) was determine by 
Equation 1.  
 
EE (%) =(
𝑚𝑒
𝑚𝑖
) x 100 
(Eq. 1) 
 
Where me is the entrapped curcumin collected in filtrate solution and mi is the initial 
mass of curcumin.  
 
2.7. Antioxidant assays  
The ability of HAs and HA-PF127 nanoparticles to scavenge free radicals was evaluated 
using two spectrophotometric methods: ABTS•+ and DPPH•. Curcumin was used as positive 
control due to its fast reactivity and high antioxidant activity. Both assays were performed in 
triplicate. 
 
2.7.1. ABTS radical decolorization assay 
This assay was performed according to the method proposed by Re et al. (1999) with 
modifications. The ABTS•+ cation radical was produced by reacting 7 mM of ABTS and 2.45 
mM of K2S2O8, which was stored in a dark room for 16 h to allow the reaction. The ABTS
•+ 
solution had a final concentration of 2.45 mM and was diluted with ethanol to give an 
absorbance of 0.70 ± 0.01 at 734 nm. Different concentrations of curcumin (5-50 µg/mL) were 
prepared in ethanol, and 300 µL of each solution was added to 2,700 µL of ABTS•+ to produce 
between 30-80% inhibition of the blank absorbance. Then, the same procedure was used for 
HAs and HA-PF127. The absorbances were recorded 30 min after mixing, and the antioxidant 
activity of the samples were calculated by Equation 2.   
 
ABTS•+ scavenging (%) = [1 – ( 
𝐴𝑠
𝐴𝑏
 ) x 100]                         (Eq. 2) 
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Where As and Ab are the absorbances of ABTS•+ in the presence and absence of the 
scavenger, respectively. 
 
2.7.2. DPPH radical decolorization assay 
 This assay was performed following the procedure proposed by Blois (1958) with 
modifications. A solution of 0.1 mM of DPPH• was prepared in ethanol and diluted to give an 
absorbance of 1.05 ± 0.01 at 517 nm. Then, 600 µL of curcumin in different concentrations (5-
50 µg/mL) was added to 2,000 µL of DPPH• to produce between 30-80% of inhibition of the 
blank absorbance. The same procedure was used to evaluate the radical scavenging abilities of 
HAs and HA-PF127. The absorbances were recorded 30 min after mixing, and the antioxidant 
activity of the samples was calculated by Equation 3: 
 
DPPH• scavenging (%) = [1 – ( 
𝐴𝑠
𝐴𝑏
 )  x 100]                           (Eq. 3) 
 
Where As and Ab are the absorbances of DPPH• in the presence and absence of the 
scavenger, respectively. 
 
2.8. Statistical analysis 
All experiments were conducted in triplicate and expressed as means ± SD. One-way 
analysis of variance (ANOVA) was performed using Microsoft® Excel. Values of p < 0.05 were 
indicative of significant differences. 
 
3. Results and Discussion  
3.1. Stability assays 
Physical stability of HAs, PF127 and HA-PF127 was evaluated by measuring size and 
zeta potential of the samples six months after preparation. Results showed that no particle 
aggregation or agglomeration occurred during storage, as presented in Table 4.2.1.  
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Table 4.2.1. Mean diameter, PDI and zeta potential measured by DLS immediately after preparation 
and six months later. 
 Immediately after preparation Six months after preparation 
 
Mean 
diameter 
(nm) 
PDI 
Zeta 
Potential 
(mV) 
Mean 
diameter 
(nm) 
PDI 
Zeta 
Potential 
(mV) 
PF127 6.89 ± 
1.20 
0.28 ± 
0.08 
-3.71 ± 
1.00 
5.73 ± 
0.96 
0.56 ± 
0.07 
-11.37 ± 
2.61 
HAs 192.41 ± 
21.08 
0.46 ± 
0.07 
-32.03 ± 
5.29 
127.79 ± 
12.29 
0.39 ± 
0.04 
-30.64 ± 
3.90 
HA-PF127 125.01 ± 
8.67 
0.44 ± 
0.03 
-28.37 ± 
6.17 
135.11 ± 
35.04 
0.45 ± 
0.08 
-28.34 ± 
2.36 
No particles aggregation was observed after six months of storage. The mean diameter 
of PF127 micelles and HA-PF127 nanoparticles slightly changed from 6.89 to 5.73 nm and 
125.01 to 135.11 nm, respectively. HAs showed a decrease of size, from 192.41 to 127.79 nm, 
suggesting a probable dissociation of HAs molecules from the pseudomicelles aggregate with 
time. Zeta potential of both HAs alone and HA-PF127 were similar after six months of storage, 
while for PF127 there was an increase in the negative value, from -3.71 to -11.37 mV. After six 
months, there was an increase in polydispersity for PF127 micelles from 0.28 to 0.56, but no 
changes was observed for HAs and HA-PF127. These results indicate that nanotechnological 
properties of HA-PF127 were ensured during a long period of storage. 
 
3.2. Membrane permeation capability 
The human skin has pores with size approximately 30 nm and a transepidermal pressure 
around 2.5 x 105 Pa (van Den Bergh et al. 2001) and membrane permeation assay was 
performed in order to simulate skin pores permeation capability. Table 4.2.2 shows the values 
of hydrodynamic diameter, PDI and zeta potential for PF127, HAs and HA-PF127 nanoparticles 
before and after particles permeation. For both PF127 micelles and HAs pseudomicelles it was 
observed particles aggregation with sizes up to 500 nm. However, for HA-PF127 it was 
observed an increase of size, from 125.01 to 171.77 nm, probable due to the association of AHs 
molecules to the structures during permeation, but no particles aggregation was observed. Zeta 
potential of all samples was between -15 and -17 mV, and polydispersity of the systems 
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increased with membrane permeation, changing from 0.28 to 0.46, 0.46 to 0.51 and 0.44 to 0.58 
for PF127, HAs and HA-PF127, respectively.   
Table 4.2.2. Mean diameter, PDI and zeta potential of PF127, HAs and HA-PF127 before and after permeation 
at 2.5 x 105 Pa. 
 
Before permeation After permeation 
Mean 
diameter 
(nm) 
PDI 
Zeta 
potential 
(mV) 
Mean 
diameter 
(nm) 
PDI 
Zeta 
potential 
(mV) 
       
PF 127 6.89 ± 
1.20 
0.28 ± 
0.08 
-3.71 ± 
1.00 
513.17 ± 
25.50 
0.46 ± 
0.16 
-15.5 ± 
2.8 
       
HAs 192.41 ± 
21.08 
0.46 ± 
0.07 
-32.03 ± 
5.29 
412.32 ± 
43.55 
0.51 ± 
0.21 
-16.6 ± 
3.5 
       
HA-PF127 125.01 ± 
8.67 
0.44 ± 
0.03 
-28.37 ± 
6.17 
171.77 ± 
22.27 
0.58 ± 
0.10 
-16.3 ± 
0.3 
 
HAs have a flexible structure due to several hydrogen bonds between the groups 
(Essington 2003; Ohashi et al. 1996), which enables them to change conformation with pH. 
This characteristic allowed the deformation of HAs pseudomicelles and their permeation 
through the small pores of the membranes. The presence of PF127 into HAs structures and their 
long PEO chain may have contributed to the permeation of HAs without causing particles 
aggregation. These results indicate that HA-PF127 nanoparticles have an elastic behavior and 
they are potentially able to permeate skin pores. 
 
3.3. HA-PF127 nanoparticles as a curcumin carrier 
The results of the hydrodynamic diameter, PDI, zeta potential and encapsulation 
efficiency (EE) obtained for curcumin in HA-PF127 (Curc-HA-PF127),  curcumin in HAs 
(Curc-HAs) and curcumin in PF127 (Curc-PF127) are shown in Table 4.2.3. The Curc-PF127 
resulted in the increase of particles size from 7 to 28 nm, and a higher negative zeta potential 
value, -9.82 mV compared to PF127 (-3.71 mV).  The results for Curc-HAs suggested that in 
the presence of curcumin, the structures aggregated more tightly forming smaller particles with 
size of 105 nm. HAs pseudomicelles accommodated curcumin in their structure without 
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changing the zeta potential value, which remained at -30.73 mV. The size of HA-PF127 
nanoparticles increased from 125 to 175 nm after encapsulation and it was observed a decrease 
of the negative value of zeta potential, going to -14.33 mV.  
  
Table 4.2.3. Size and zeta potential of the nanoparticles, and EE of curcumin loaded in PF127, HAs and HA-
PF127. Values of EE followed by the same letters are not significantly different (p < 0.05). 
Condition Size (nm) PDI 
Zeta potential 
(mV) 
EE (%) 
Curc-PF127 28.23 ± 6.95 0.26 ± 0.04 -9.82 ± 1.09 0.35 ± 0.19a 
Curc-HAs 105.34 ± 16.44 0.44 ± 0.07 -30.73 ± 4.48 3.38 ± 0.56b 
Curc-HA-PF127 175.11 ± 49.17 0.42 ± 0.20 -14.33 ± 4.72 2.94 ± 0.86b 
The particles displayed an EE between 0.3 and 4%. The entrapment of curcumin into 
PF127 micelles was below 1%, probably due to the low PF127 concentration (0.1% w/v), which 
was not sufficient for the covering of curcumin. HAs showed to have the higher EE (3.38%). 
EE of HA-PF127 was 2.94%, indicating that the PF127 may have acted as a barrier to the 
curcumin diffusion when associated with HAs.  
Both substances associate mainly by hydrophobic interactions, where PPO fraction of 
the surfactant incorporates in the hydrophobic core of the pseudomicelles, forming a structure 
with a dense core filled with HAs and PF127 portions, as suggested by the illustration of Figure 
4.2.1. This dense core added to the PEO fractions of PF127 may have limited the entrapment 
of curcumin, which resulted in a low value of EE. 
 
Figure 4.2.1. Illustration of HA-PF127 interactions and the entrapment of curcumin in the structure. 
 PF127 micelles interact with 
HAs structures
HA-PF127 nanoparticles 
with dense core
Few available sites for 
curcumin entrapment
Curcumin
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3.4.  ABTS and DPPH radical scavenging activity 
The antioxidant activity of HAs was determined by measuring their capacity to scavenge 
ABTS and DPPH radicals, which are two widely used spectrophotometric methods known for 
being simple and efficient (Li et al. 2013). Curcumin is a known antioxidant, which has a fast 
reactivity, and was used in these assays as a positive control (Candan et al. 2003). Figure 4.2.2A 
shows the inhibitory effect of the positive control, HAs and HA-PF127 on ABTS•+ in a 
concentration-dependent manner. Radical scavenging by curcumin varied from 25.2 ± 6.5% to 
81.5 ± 8.6%, while for HAs and HA-PF127 the range was between 11.7 ± 1.2% to 15.9 ± 0.5% 
and from 13.5 ± 0.3% to 18.6 ± 1.0%, respectively.  
Figure 4.2.2B shows the inhibitory effect of the positive control on DPPH•, which varied 
from 31.2 ± 3.9% to 78.2 ± 6.0%. However, for HAs and HA-PF127, it was not observed 
response on radical scavenging in a dependent concentration manner, being around 22% for all 
concentrations.  
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Figure 4.2.2. Antioxidant activity of curcumin (positive control), HAs and HA-PF127 at different 
concentrations (5-50 µm/mL) on ABTS
•+
 (A) and DPPH
•
 (B). *Significant difference was found between the 
groups (p < 0.05). 
Antioxidants can deactivate free radicals through two mechanisms: 1) By electron 
transfer, in which the antioxidant can transfer an electron to the free radical becoming itself a 
radical; and 2) by H-atom transfer, in which hydrogen is removed from the antioxidant by the 
radical (Wright et al. 2001). 
The ABTS•+ method involves an electron-transfer process from the antioxidant to the 
radical, which leads to the decolorization of the green/blue ABTS•+ solution, indicating that the 
radical is reduced through the following reaction: 
 
ABTS•+ + R-OH → ABTS+ + R-O• 
 
 
0 10 20 30 40 50
0
10
20
30
40
50
60
70
80
90
100
 Curcumin (Positive control)
 HA
 HA-PF127
%
 A
B
T
S
.+
 S
c
a
v
e
n
g
in
g
Concentration (g/ml)
*
*
A
B
0 10 20 30 40 50
0
10
20
30
40
50
60
70
80
90  Curcumin (Positive control)
 HA
 HA-PF127
%
 D
P
P
H
. S
c
a
v
e
n
g
in
g
Concentration (g/ml)
 87 
 
Differently, the DPPH• method involves an H-atom transfer process, which results in the 
decrease of the absorbance due to decolorization of the purple solution. The H-atoms is 
transferred from an antioxidant to DPPH• through the following reaction: 
 
DPPH• + R-OH → DPPH-H + R-O• 
 
HAs have a weak acid behavior due to the presence of phenols and carboxylic acids 
(Schnitzer 1977), with a pKa that can vary from 3.0 to 6.0 (Kluĉáková  & Kolajová, 2014), 
depending on the origin of HAs. In neutral pH, a fraction of phenolic and carboxylic groups’ 
deprotonate transferring protons to the medium. This behavior allows HAs structures, which 
have negative charges, to transfer electrons to ABTS•+ and form stable radicals, as shown in the 
illustration of Figure 4.2.3A.  
It was observed that the ABTS•+ scavenging was dependent of HAs concentration, being 
the percentages of scavenging for 5 and 50 µg/mL significantly different (p < 0.05). The 
formation of nanocomplex by hydrophobic interactions between PF127 and HAs may provide 
more hydroxyls to the outside of the structure leading to an increase in the number of groups 
available for reducing ABTS free radicals. However, the statistical analysis indicated that 
presence of PF127 did not altered significantly the percentage of radical scavenging compared 
to HAs alone (p < 0.05). 
 
 
Figure 4.2.3. Illustration of the two mechanisms of free radicals deactivation by HAs. ABTS•+ (A). 
DPPH• (B). 
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DPPH• was reduced by HAs through H-atom transfer due to the presence of protonated 
groups in their structures (Figure 4.2.3B). However, it was not observed an effect with 
concentration, probably due to HAs behavior that tends to coil up with increasing concentration 
(Ghosh & M. Schnitzer 1980). This behavior may not allow more protonated groups to be 
exposed to the medium and react with free radicals. Therefore, HAs in neutral pH have 
antioxidant activities in a concentration dependence manner when the scavenging of free 
radicals depend exclusively on electron transfer. By decreasing pH, it is possible that more 
protonated groups will be available for reactions that depend on H-atom transfer. 
 
4. Conclusions 
In this study, the association of HAs and PF127 produced nanocomplex with nanometric 
size, which remained stable for six months. HA-PF127 were capable of permeating two 30 nm 
polycarbonate membranes, which indicates their potential permeation through the pores of 
human skin, which have approximately 30 nm of diameter. The presence of the surfactant 
contributed to the permeation of HAs with no particles aggregation, probably due to their long 
hydrophilic portions. However, the dense core of HA-PF127 and PEO chains of PF127 may 
have acted as a diffusion barrier to the curcumin incorporation, as EE was lower for HA-PF127 
compared to HAs alone. The antioxidant assays showed that HAs were able to scavenge ABTS 
radicals in a concentration dependence manner. On other hand, dose response activity toward 
DPPH radicals was not observed because increasing HAs concentration, the molecules tends to 
coil up, not providing more protonated groups for the reaction. These results show the feasibility 
of the production of spherical and stable nanoparticles through association between HAs and 
PF127, with potential to permeate through human pores and to be used in pharmaceutical 
applications.  
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5. CONCLUSÕES  
Os resultados obtidos deste trabalho contribuirão para a aplicação nanotecnológica dos 
AHs na área farmacêutica. A produção de nanopartículas demonstrou que ocorreram interações 
hidrofóbicas entre AHs e PF127 pela adição gradual de AHs ao tensoativo, sob agitação 
constante. Essa produção foi favorecida pela maior razão AH/PF127, onde houve 
predominância de nanopartículas AH-PF127 na dispersão, com diâmetro hidrodinâmico médio 
de aproximadamente 100 nm. Maiores razões molares também garantiram estabilidade 
eletrostática, obtendo-se potencial zeta de -30.23 e -15,52 mV para AH:PF127 1:80 e 1:800 
(mol:mol), respectivamente. A análise de microscopia eletrônica de varredura (MEV) mostrou 
que as nanopartículas produzidas são esféricas e confirmaram o seu tamanho, de 
aproximadamente 100 nm. 
Quanto à caracterização dos grupos funcionais dos AHs, empregando os métodos de 
RMN 13C, EM-CG e FTIR, foi observado que aproximadamente 30% do total da amostra era 
composta de fenóis e ácidos carboxílicos, os quais são responsáveis pelo seu caráter 
antioxidante. No entanto, os resultados do ensaio antioxidante de sequestro do ABTS indicaram 
baixa atividade, em comparação com o controle positivo, porém a atividade mostrou dose 
dependência. A presença do tensoativo não foi significativamente diferente dos resultados 
obtidos para os AHs. Com relação à atividade antioxidante contra o DPPH, cujo sequestro do 
radical depende da transferência de H+, não foi observada atividade antioxidante dependente da 
concentração tanto na ausência quanto na presença do tensoativo. Esses resultados mostraram 
que em pH neutro, os grupos funcionais protonados não ficam disponíveis para reação com o 
aumento da concentração de AHs, possivelmente devido ao aumento do enovelamento das 
moléculas.  
A caracterização dos AHs não apontou a presença de grupos quinonas, e como 
consequência, não foi observada atividade fungicida na amostra em função do aumento da 
concentração de AHs, tanto na presença quanto na ausência de PF127. No entanto, o tensoativo 
disponibilizou mais grupos carboxílicos ao meio, o que pode ser atribuído ao ligeiro aumento 
da inibição de crescimento do fungo, como mostrado no APÊNDICE deste trabalho. 
Os resultados de permeação em membrana mostraram que as nanopartículas AH-PF127 
foram capazes de permear duas membranas de policarbonato, de poros de 30 nm, que simularam 
a permeação pelos poros da pele. A presença do tensoativo facilitou a passagem dos AHs sem 
agregação das nanopartículas. Esses resultados demonstram o potencial dessas nanopartículas 
para utilização em aplicação tópica. No entanto, estudos de permeação em pele são necessários. 
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A EE da curcumina em nanopartículas AH-PF127 foi de 2,94%, superior à eficiência 
das micelas de PF127, que foi abaixo de 1%. Isso provavelmente devido à baixa concentração 
do tensoativo, não sendo suficiente para recobrir a curcumina. Porém, a EE das AH-PF127 foi 
menor em relação aos AHs sem PF127, o que pode ser atribuído à grande porção hidrofílica 
PEO do tensoativo, que pode ter atuado como uma barreira difusiva para a incorporação da 
curcumina. Sendo assim, estudos utilizando outros tensoativos são necessários. 
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6. SUGESTÕES PARA TRABALHOS FUTUROS 
 Estudo das interações entre os AHs e outros tensoativos comumente utilizados no preparo 
de nanopartículas para aplicações farmacêuticas, como o Pluronic P123 e o Pluronic L121, 
que possuem porções hidrofílicas 5 e 20 vezes menor do que as do PF127, respectivamente. 
 Realização de ensaios antioxidantes por outros métodos que envolvem transferência de 
elétrons, como o ensaio Folin-Ciocalteu (FCR) e o ensaio de poder redutor de íons ferro 
(FRAP); 
 Estudo de encapsulação de diferentes fármacos nas nanopartículas de ácidos húmicos, por 
exemplo, reverastrol e quercetina, dois polifenóis de baixa solubilidade em água e que 
possuem atividades antioxidante e anti-inflamatória. 
 Reprodução dos estudos realizados com AHs obtidos de outras fontes, tais como por 
fermentação e/ou solo, rios e sedimentos (obtidos através da International Humic 
Substances Society, IHSS), os quais contenham grupos funcionais relacionados às 
atividades antioxidante, anti-inflamatória e fungicida; 
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APÊNDICE 
 
1. Ensaio fungicida in vitro 
 
1.1. Material e Métodos 
A atividade fungicida dos AHs Sigma-Aldrich e das nanopartículas AH-PF127 foi 
testada de acordo com a metodologia descrita por Sidiqui et al. (2009), utilizando-se o fungo 
Candida albicans, responsável por diversas infecções em humanos. O ensaio foi realizado para 
AHs nas concentrações 0 (controle), 10, 55, 100, 200 e 300 µg/mL tanto na presença quanto na 
ausência de PF127. A razão AH:PF127 1:8 (mol:mol) foi mantida em todas as amostras 
contendo PF127. 
As amostras foram preparadas e esterilizadas por filtração em membrana de 
polietersulfona (PES) com poros de 0,22 µm (TPP, Suíça). As amostras esterilizadas foram 
adicionadas ao meio ágar batata dextrose (BDA) (Oxoid) e, em seguida, o meio de cultura foi 
vertido em placas de Petri. Após solidificação do meio, foram inoculados, na superfície de cada 
placa, 3 discos de 5 mm de diâmetro contendo o fungo Candida albicans CCT 0776 
previamente cultivado em BDA puro. As placas contendo os discos permaneceram incubadas 
a 30 °C por 5 dias. A porcentagem de inibição em crescimento radial (PICR) foi medida de 
acordo com a Eq. 1, adaptada do método descrito por Jinantana & Sariahi (1998). Foram 
realizadas 5 replicatas de cada concentração com 3 discos de inoculação cada. 
 
𝑃𝐼𝐶𝑅(%) =
𝑅1 − 𝑅2
𝑅1
∙ 100% 
Eq. 1 
Onde: 
R1 = Raio da colônia de fungo nas placas controle. 
R2 = Raio da colônia de fungo nas placas contendo AHs e AH-PF127. 
 
1.2. Resultados e Discussão 
 
Os resultados obtidos da incubação do fungo C. albicans com os AHs e as 
nanopartículas AH-PF127, que consistem do diâmetro de crescimento do fungo e a PICR para 
todas as concentrações de AHs, estão apresentados na Tabela 1. Na presença de apenas AHs, é 
possível observar que não existe uma dose-dependência da inibição (PICR). Para AHs 300 
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µg/mL, a amostra de maior concentração e, portanto, a qual esperava-se maior inibição de 
crescimento, a PICR foi de apenas 0,87%, enquanto para AHs 10 µg/mL esse valor foi de 
3,91%.  
 
Tabela 1. Diâmetro de crescimento e PICR das amostras de AHs e AH-PF127 para diferentes concentrações de 
AHs. 
 AHs AH-PF127 
Concentração 
AHs (µg/mL) 
Diâmetro de 
Crescimento 
(mm) 
PICR (%) 
Diâmetro de 
Crescimento 
(mm) 
PICR (%) 
0 (controle) 15,33 ± 1,05 --- 16,47 ± 0,64 --- 
10 14,73 ± 0,96 3,91 15,07 ± 0,80 9,13 
55 15,00 ± 1,25 2,71 15,67 ± 1,35 5,22 
100 15,20 ± 1,15 0,87 15,87 ± 0,74 3,91 
200 14,53 ± 1,06 5,22 15,40 ± 0,74 6,96 
300 15,20 ± 0,86 0,87 15,80 ± 1,01 4,35 
 
Com relação aos ensaios utilizando-se nanopartículas de AH:PF127, observa-se que o 
maior PICR foi também para a amostra de menor concentração de AHs, 9,13%. Portanto, estes 
ensaios, assim como obtido apenas para os AHs, não apresentaram inibição de crescimento do 
fungo de maneira dose dependente, sendo que para a amostra de maior concentração de AHs, a 
PICR foi de 4,35%. No entanto, os resultados indicam que a presença do PF127 pode ter 
influenciado na inibição do crescimento do fungo, uma vez que, na presença do tensoativo, as 
porcentagens de inibição obtidas foram maiores do que quando foram utilizados apenas AHs 
para todas as concentrações empregadas. A maior inibição do crescimento pode ser explicada 
pelo fato de que na presença do tensoativo PF127 há um aumento da exposição dos grupos 
carboxílicos presentes no interior das pseudomicelas de AHs, os quais ficam em contato com o 
meio. De acordo com Siddiqui et al. (2009), a presença de ácidos carboxílicos pode estar 
relacionada com o efeito fungicida dos AHs, através de sua ligação direta com o fungo.  
Embora Siddiqui et al. (2009) tenham atribuído o efeito fungicida observado em seu 
trabalho aos grupos carboxílicos, estes mesmos autores referem-se aos grupos quinonas como 
os maiores responsáveis por ações fungicida e bactericida. Os grupos quinonas são facilmente 
reduzidos em semiquinonas que, por sua vez, produzem espécies reativas de oxigênio (EROs) 
em contato com o oxigênio molecular. Esses radicais livres promovem o estresse oxidativo nas 
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células dos fungos e bactérias causando sua morte (Fujimura et al. 1994; Hassett et al. 1987; 
Siddiqui et al. 2009). No entanto, a presença de grupos quinonas nos AHs não foi identificada 
pelas análises de RMN 13C, EM-CG e FTIR, refletindo em baixas PICRs, como observado na 
Tabela 1. Em seu trabalho, Siddiqui et al. (2009) relataram alta atividade fungicida promovida 
pelos AHs Sigma-Aldrich no fungo Choanephora cucurbitarum, com porcentagem de inibição 
de aproximadamente 40% para AHs 250 µg/mL. Os autores realizaram FTIR dos AHs e 
observaram a presença de quinonas nas amostras, atribuindo, portanto, sua alta atividade 
fungicida à presença desses grupos. Embora no presente trabalho tenham sido utilizados AHs 
provenientes da Sigma-Aldrich, sua origem da extração, condições climáticas, dentre outros 
fatores, não foram disponibilizadas pelo fornecedor, os quais podem influenciar nas 
características dos AHs. 
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